Stockwinners Market Radar for February 08, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
ACHR | Hot Stocks20:26 EST Cathie Wood's ARK Investment bought 344K shares of Archer Aviation today
|
PINS | Hot Stocks20:25 EST Cathie Wood's ARK Investment bought 990K shares of Pinterest today
|
DOLE | Hot Stocks20:18 EST Dole Fresh Vegetables recalling number of salad kids - Dole Fresh Vegetables, Inc. is voluntarily recalling from the market a limited number of Dole-branded and private label salad kits described below, which were processed on the same line as a cheese that has been recalled by the manufacturer, Rizo-Lopez Foods, for the possible presence of Listeria monocytogenes.
|
WY | Hot Stocks19:43 EST Weyerhaeuser raises quarterly dividend by 5.3% to 20c per share - The dividend is payable in cash on March 22, 2024, to holders of record of such common stock as of the close of business on March 8, 2024.
|
CHCT | Hot Stocks19:16 EST Community Healthcare raises quarterly dividend to 45.75c per share from 45.5c - The dividend is payable on March 1, 2024 to shareholders of record on February 20, 2024.
|
AESI | Hot Stocks19:14 EST Atlas Energy raises quarterly dividend 5% to 21c per share - Dividend is to be paid on February 29, 2024, to holders of record of our common stock at the close of business on February 22, 2024.
|
ATSG | Hot Stocks18:46 EST Omni Air pilots vote to authorize a strike - Omni Air International pilots who are represented by the Airline Professionals Association-Teamsters Local 1224 voted to authorize a strike, with 100% of participating members voting in favor of the action. This strike authorization allows Teamsters Local 1224's leadership to call a strike on behalf of the pilot group, if necessary and when legally permitted under the Railway Labor Act. Omni Air pilots have been in negotiations for an amended collective bargaining agreement for nearly three years. Progress toward a new contract has stalled, despite eight months of federally mediated negotiations. Other labor groups at the company, including Omni Air's flight attendants and dispatchers are facing similar circumstances. Air Transport Services Group acquired Omni Air in 2018.
|
V | Hot Stocks18:40 EST Visa exec Andreski sells 2,615 class A shares - In a regulatory filing, Visa CAO Peter Andreski disclosed the sale of 2,615 class A common shares of the company on February 7 at a price of $278.8841 per share.
|
IRON | Hot Stocks18:27 EST Disc Medicine's treatment of Polycythemia Vera gets FDA orphan designation - According to a post on the FDA's website, Disc Medicine's treatment of Polycythemia Vera received orphan designation. Reference Link
|
TAK | Hot Stocks18:02 EST Takeda to rapidly initiate the first global Phase 3 trials of TAK-861 - Takeda announced positive topline results from a randomized, double-blind, placebo-controlled, multiple dose Phase 2b trial evaluating TAK-861, an oral orexin receptor 2 agonist, in patients with narcolepsy type 1. The NT1 trial TAK-861-2001 evaluating TAK-861 in 112 patients demonstrated statistically significant and clinically meaningful improvement in objective and subjective measures of wakefulness compared to placebo at week 8 including on the primary endpoint Maintenance of Wakefulness Test. Improvements in key secondary endpoints including Epworth Sleepiness Scale and Weekly Cataplexy Rate were statistically significant and clinically meaningful, consistent with the primary endpoint. The majority of patients who completed the trial entered a long-term extension study. Based on these results, and in consultation with global health authorities, Takeda plans to initiate global Phase 3 trials of TAK-861 in NT1 rapidly in the first half of its fiscal year 2024. At this time, Takeda does not plan to advance TAK-861 in NT2. Data are being further analyzed to determine next steps in orexin normal populations. Takeda is progressing multiple orexin agonists in patient populations with normal levels of orexin neuropeptides such as NT2 and other indications where orexin biology is implicated. TAK-861 was generally safe and well tolerated in both trials. No treatment related serious adverse events were reported. In addition, no cases of hepatotoxicity or visual disturbances were reported in the Phase 2b trials or in the ongoing TAK-861 long-term extension trial.
|
MWA | Hot Stocks17:54 EST Mueller Water advances over 5% after Q1 results exceed estimates - Shares of Mueller Water are up 71c of 5.10% in after-hours trading on Thursday to $14.60 after the company reported quarterly results that beat analyst expectations on the top and bottom lines.
|
AFRM | Hot Stocks17:42 EST Affirm says 'very upbeat' about GMV opportunity - CFO Michael Linford says: "Just like we have all year long for the full year, we're only providing a floor or our full year guide. And so we did take our (GMV) floor up by $1B, which we think is a pretty big step up in what we would expect for the year. We remain very upbeat and excited about the opportunity."
|
AFRM | Hot Stocks17:40 EST Affirm raises FY24 GMV forecast to over $25.25B - Prior FY24 GMV forecast was over $24.25B. Raises operating margin view to over 11% from over 5%. Comments taken from investor presentation slides.
|
NVX PCRFY | Hot Stocks17:39 EST Novonix and Panasonic Energy sign binding off-take agreement for graphite anode - Novonix (NVX) and Panasonic (PCRFY) Energy, a manufacturer of electric vehicle batteries in North America, signed a binding off-take agreement for high-performance synthetic graphite anode material to be supplied to Panasonic Energy's North American operations from Novonix's Riverside facility in Chattanooga, Tennessee. Panasonic Energy has agreed to purchase at least 10,000 tons of anode material for use in their U.S. plants over the term of 2025-2028. During the term, if additional volumes are requested by Panasonic Energy, Novonix wonn use its best efforts to deliver the increased volumes. Panasonic Energy is working to expand its production of EV batteries in North America to meet increased demand while also increasing the percentage of materials procured locally. Novonix's Riverside facility is set to become the first large-scale production site dedicated to high-performance synthetic graphite for the battery sector in North America and is slated to begin production in late 2024, with plans to grow output to 20,000 tons per annum to meet anticipated customer demand.
|
CNS | Hot Stocks17:30 EST Cohen & Steers reports January-end AUM $79.3B, down $3.8B from December - Cohen & Steers "reported preliminary assets under management of $79.3 billion as of January 31, 2024, a decrease of $3.8 billion from assets under management at December 31, 2023. The decrease was due to market depreciation of $2.2 billion, net outflows of $1.5 billion, and distributions of $157 million."
|
AFRM | Hot Stocks17:26 EST Affirm reports Q2 active customers up 13% from last year at 17.6M - Reports Q2 active merchants up 15% at 279K.
|
EXPE | Hot Stocks17:23 EST Expedia says has further room to optimize cost structure - Says anticipates that market growth rates will moderate in 2024 given the absence of COVID-driven tailwinds that were prominent last year. Says expects to have another strong year with top line year-over-year growth relatively in line with what we saw in 2023. Says believes we have further room to optimize cost structure and therefore improve margins. Says expects to continue to drive operating efficiencies and cost of sales across customer support and other operations.
|
FBP | Hot Stocks17:17 EST First BanCorp increases quarterly cash dividend on common stock14% to 16c - First BanCorp has declared a quarterly cash dividend of 16c per share, an increase of 14% or 2c per common share compared to its most recent dividend paid in December 2023. The dividend is payable on March 8, 2024 to shareholders of record at the close of business on February 23, 2024.
|
SVM | Hot Stocks17:10 EST Silvercorp Metals provides Q4 production guidane - Silvercorp Metals expects to process 215,000-240,000 tons of ore to produce approximately 1,200 to 1,300 ounces of gold, 1.1 to 1.3 million ounces of silver, 11.5 to 13.5 million pounds of lead, and 4.5 to 5.0 million pounds of zinc, representing production increases of 11% to 30% in ore, 20% to 30% in gold, 0% to 17% in silver, 5% to 20% in lead, and 26% to 40% in zinc compared to the production results in the same quarter last year.
|
PINS | Hot Stocks17:04 EST Pinterest pares afterhours losses following Google ad integration announcement - Shares of Pinterest are now down 7.5% or $3.05 at $37.67 after the company CEO disclosed Google ad integration with conference call commentary. Shares had initially traded down by over 20% following the company's Q4 results.
|
PINS GOOGL | Hot Stocks17:02 EST Pinterest discloses 3rd-party ad integration with Google - CEO William Ready stated: "Today, I'm pleased to announce our next third-party ad integration with Google. This partnership will focus on monetizing several of our currently unmonetized international markets by enabling ads to be served on Pinterest via Google's Ad Manager. We went live a couple of weeks ago, and this is starting to ramp. Third-party ad demand is scaling as we anticipated. And while it was not a significant revenue contributor in Q4, we are now seeing it contribute more meaningfully to our growth this quarter, and we expect that to continue going forward." Comments taken from Q4 earnings conference call.
|
NEXA | Hot Stocks16:56 EST Nexa Resources reports Q4 and FY23 exploration results - Nexa Resources provided the drilling and assay results from Q4 and full year of 2023. At the end of 2023, cumulative drilling production reached 257,482 meters, of which 85,199 meters were exploratory drilling, including the Babacu infill at Aripuana, and 172,284 meters were operational infill drilling. Total exploratory drilling in 4Q23 was 15,586 meters. Exploratory drilling planned for 1Q24 includes 9,500 meters in Peru with seven rigs and 2,500 meters in Brazil with three rigs, totaling 12,000 meters. Jones Belther, Senior Vice President of Mineral Exploration & Business Development, said "During 2023 we achieved 97% of the planned activities with the execution of 85,199 meters of exploratory drilling out of the planned 88,196 meters...During 4Q23 our brownfield exploration programs have progressed as planned and assay results continue to indicate that we can potentially extend the life of mine of our current operations. At Cerro Lindo, orebodies OB-8 and OB-9 continued to be extended with intersections greater than 4.0 meters...At the Pasco complex, the Integracion orebody confirmed continuity in depth below the 3300 level in three holes as per hole PEEPD02702 with 3.5 meters @ 2.99% Zn, 1.15% Pb, 0.46% Cu, 130.97 g/t Ag and 0.42g/t Au. Finally, in respect of the Hilarion project, at the El Padrino area, two holes confirmed mineralized skarn zone continuity to the southwest, displaying multiple parallel lenses as was the case with hole PEPADD000001 with 6.2 meters @ 2.70% Zn, 0.37% Pb, 0.431% Cu, and 38.08g/t Ag".
|
GEG GECC | Hot Stocks16:47 EST Great Elm Group invests $6M to support Great Elm Capital equity raise - Great Elm Group (GEC) announced it has invested $6M in a special purpose vehicle which acquired $24M of common stock in Great Elm Capital (GECC) at net asset value, or NAV. "This transaction leverages GEG's key attributes to create a beneficial outcome for all stakeholders," said Jason Reese, GEG's Chief Executive Officer. "Raising equity at NAV for our permanent capital vehicle, GECC, will help leverage our infrastructure and help scale our credit platform. In addition, we believe our investment in the special purpose vehicle will deliver a strong return and allow us to grow our recurring revenue streams. GEG is committed to scaling its existing businesses and executing its strategic growth initiatives."
|
SYBX | Hot Stocks16:46 EST Synlogic sinks 52% to $1.67 after ending study and operations
|
SECO | Hot Stocks16:45 EST Secoo Holding receives additional delist notice from Nasdaq - Secoo Holding announced that it received an additional delist notice from Nasdaq on February 6. The delist notice from Nasdaq dated February 6 notified the company that, upon further review, the Nasdaq Staff has determined that in light of concerns regarding the circumstances surrounding the company's failure to file its delinquent reports, it no longer appears to Nasdaq that it is possible for the company cure the deficiency. This matter serves as an additional basis for delisting the company's securities from Nasdaq. The company plans to present its views with respect to this additional deficiency at its Nasdaq Panel hearing scheduled on February 13.
|
SYBX | Hot Stocks16:45 EST Synlogic trading resumes
|
SYBX | Hot Stocks16:43 EST Synlogic to cease operations, reduce workforce by over 90% - Synlogic said it will cease operations and reduce its workforce by more than 90%, retaining only certain employees to assist in the strategic review and assist in the discontinuation of the study. The majority of impacted roles will end in February. The company's cash, cash equivalents and short-term investments balance at December 31, 2023 was $47.7M. Aoife Brennan is also departing as President and Chief Executive Officer as part of the reduction, and stepping down from the board. Synlogic "plans to conduct an assessment of strategic options to enhance shareholder value, which will include, but are not limited to, an acquisition, merger, reverse merger, other business combination, sales of assets, dissolution or other strategic transactions." The company has not set a timetable for completion of this strategic review.
|
MRCY | Hot Stocks16:42 EST Mercury Systems appoints Douglas Munro VP and Chief Accounting Officer - Mercury Systems announced the appointment of Douglas Munro as Vice President and Chief Accounting Officer, effective February 12 .."We are very pleased for Doug to step into this important leadership position in our Finance organization," said Mr. Farnsworth. "His wealth of knowledge about our business and financial operations will serve us well going forward." Munro succeeds Michelle McCarthy, who has accepted another role outside the Company.
|
SYBX | Hot Stocks16:41 EST Synlogic ends Synpheny-3 study, to evaluate strategic options - Synlogic announced the decision to discontinue Synpheny-3, its ongoing pivotal study of labafenogene marselecobac as a potential treatment for phenylketonuria. As a result, Synlogic's management and its board have made the decision to evaluate strategic options for the company. The decision to end Synpheny-3 is based on results of an internal review in advance of an upcoming independent Data Monitoring Committee assessment, which indicated the trial was unlikely to meet its primary endpoint, the company said in a statement.
|
MNY | Hot Stocks16:39 EST MoneyHero announces resignation of CFO, COO Shaun Kraft - MoneyHero Limited announced the resignation of Shaun Kraft, the Company's Chief Financial Officer, CFO and Chief Operating Officer, COO effective May 4...Following his departure, Mr. Kraft will remain available to MoneyHero in an advisory capacity to further support the transition of his role and responsibilities.
|
AMRX | Hot Stocks16:36 EST Amneal provides complete response resubmission to FDA for IPX203 NDA - Amneal Pharmaceuticals announced that it has provided a Complete Response resubmission to the U.S. Food and Drug Administration FDA for IPX203, a novel, oral formulation of carbidopa/levodopa CD/LD extended-release capsules for the treatment of Parkinson's disease PD The original NDA for IPX203 resulted in a Complete Response Letter (CRL) from FDA. The resubmission package included data from a healthy volunteer study which was conducted in the fourth quarter of 2023. The FDA did not request any other studies. "We are pleased to provide our complete response resubmission for IPX203 as we look to expand our Parkinson's franchise," said Chirag and Chintu Patel, Co-Chief Executive Officers at Amneal. "We look forward to launching this much-needed treatment in the second half of 2024, subject to FDA approval."
|
SYBX | Hot Stocks16:34 EST Synlogic to cease ops, reduce workforce by 90% after Synpheny-3 dicontinuation - As a result of this process, Synlogic will cease operations, and reduce its workforce by more than 90%, retaining only certain employees to assist in the strategic review and assist in the discontinuation of the study. The majority of impacted roles will end in February 2024....cash, cash equivalents and short-term investments balance at December 31, was $47.7M...
|
EPAC | Hot Stocks16:31 EST Enerpac Tool CFO Colucci to step down - Enerpac Tool Group announced that Anthony Colucci is stepping down as Executive Vice President and Chief Financial Officer to assume an executive role at a private equity firm. He will remain as CFO through March 1, 2024, to assist with the transition. The company has initiated a comprehensive search to identify Enerpac's next CFO and has retained a leading executive search firm to assist with the process. In the interim, P. Shannon Burns has been appointed as Interim Principal Financial Officer and Patrick Dawson has been appointed as Interim Principal Accounting Officer. Paul Sternlieb, President and CEO of Enerpac Tool Group, said, "Since joining Enerpac, Tony has been a valued partner in the successful implementation of our ASCEND transformation program, which reached the expected benefits a year ahead of plan and has enabled us to create a far more efficient, productive, and profitable enterprise. On behalf of the Enerpac Board and management team, I want to thank Tony for his contributions and wish him all the best in his new position."
|
VCTR | Hot Stocks16:31 EST Victory Capital raises quarterly dividend 5% to 33.5c per share - Victory Capital said its board increased its regular quarterly cash dividend by 5% to 33.5c per share.
|
CRVS | Hot Stocks16:31 EST FDA grants Corvus Pharmaceuticals' Soquelitinib ODD for PTCL treatment - Corvus Pharmaceuticals announced that the U.S. Food and Drug Administration FDA granted Orphan Drug Designation for soquelitinib for the treatment of T cell lymphoma. Soquelitinib, the Company's lead ITK inhibitor candidate, is expected to advance into a Phase 3 registrational clinical trial in patients with relapsed peripheral T cell lymphoma PTCL in the second quarter 2024. "Peripheral T cell lymphoma is an aggressive subset of non-Hodgkin's lymphoma typically associated with a poor prognosis," said Richard A. Miller, M.D., co-founder, president and chief executive officer of Corvus. "For these patients, there is significant need for new therapies given that existing drugs provide limited efficacy and are associated with significant toxicity. There are no FDA approved agents for relapsed PTCL. The orphan drug designation is an important milestone in the development of soquelitinib that reinforces the unmet need for patients with T cell lymphoma." FDA Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people in the United States. Orphan drug status provides benefits to drug developers, including assistance in the drug development process, tax credits for clinical costs, exemptions from certain FDA fees and seven years of post-approval marketing exclusivity.
|
SYBX | Hot Stocks16:30 EST Synlogic to resume trading at 4:45 pm ET - Synlogic is set to resume trading at 4:45 pm ET, with quotes resuming at 4:40 pm ET, according to Nasdaq.
|
SYBX | Hot Stocks16:28 EST Synlogic to discontinue Synpheny-3 study, evaluate strategic options - Synlogic announced the decision to discontinue Synpheny-3, its ongoing pivotal study of labafenogene marselecobac SYNB1934 as a potential treatment for phenylketonuria PKU . As a result, Synlogic's management and its Board of Directors have made the decision to evaluate strategic options for the Company. The decision to end Synpheny-3 is based on results of an internal review in advance of an upcoming independent Data Monitoring Committee DMC assessment, which indicated the trial was unlikely to meet its primary endpoint. The decision was not based on concerns regarding safety or tolerability. Synlogic will now work with the Synpheny-3 clinical trial sites involved to implement the discontinuation. "It is with a heavy heart that we share this news, and our resulting decision to end Synpheny-3. Based on the program's progress and data to date, we had expected the study to demonstrate the potential for SYNB1934 to provide an important new treatment option for those affected by PKU," said Aoife Brennan, M.B. Ch.B., Synlogic President and Chief Executive Officer. "We express our deep gratitude for the support and partnership we have received from the PKU community, including the clinical trial site investigators and staff." Synlogic's Board of Directors plans to conduct an assessment of strategic options to enhance shareholder value, which will include, but are not limited to, an acquisition, merger, reverse merger, other business combination, sales of assets, dissolution or other strategic transactions. There can be no assurance that the exploration of strategic alternatives will result in any agreements or transactions, or that, if completed, any agreements will be reached, or transactions will be successfully consummated or on attractive terms. As a result of this process, Synlogic will cease operations, and reduce its workforce by more than 90%, retaining only certain employees to assist in the strategic review and assist in the discontinuation of the study. The majority of impacted roles will end in February 2024. Our cash, cash equivalents and short-term investments balance at December 31, 2023 was $47.7M... Dr. Brennan is also departing as President and Chief Executive Officer as part of the reduction, and stepping down from the Board of Directors. .
|
MRAI | Hot Stocks16:27 EST Marpai signs two financial agreements - Marpai announced two financing agreements. The company executed an amendment to the Maestro Purchase Agreement with AXA. The amendment provides an overall extension to the payment terms, significantly reduces the remaining payment in 2024 to $473,688 and delays any further payments to 2025. In addition, AXA has agreed to certain "Reduction Criteria" that would potentially reduce the overall payment obligation by $3M once certain criteria are met, including the company maintaining its Nasdaq or other national securities exchange listing. As a part of that criteria, Mr. Lamendola, as the company's largest shareholder, has committed to investing at least $3M in equity during 2024. Separately, Marpai received $1.7M in revenue-based financing from Libertas Funding. Libertas has provided access to over $2.6B in funding for small and medium-sized businesses since its inception in 2016. The company expects to use the funds for short-term working capital needs.
|
NET AYX | Hot Stocks16:26 EST Cloudflare names Mark Anderson president of revenue - Cloudflare (NET) announced the appointment of Mark Anderson, a current member of Cloudflare's Board of Directors, as President of Revenue to further accelerate the company's next phase of growth at scale to $5 billion in annual recurring revenue and beyond. Anderson most recently served as the CEO of Alteryx (AYX) and brings 25+ years of experience building high performing teams and scaling revenue at multiple enterprise technology companies. "I've had the privilege of working closely with Mark since 2019 when he joined Cloudflare's Board of Directors. It's not often that a such a unique opportunity like this presents itself - hiring a respected industry veteran with a proven track record of driving growth at scale across multiple enterprise technology organizations, who also has a deep knowledge of our business, leadership, and team," said Matthew Prince, CEO and co-founder at Cloudflare. "Mark has been part of our growth journey for more than four years, and bringing him on to drive our go-to-market efforts was an exceptional opportunity we simply could not pass up. I'm personally excited to work closely with him, and we are thrilled to welcome him to the team as we continue to build a world-class sales organization."
|
CBL | Hot Stocks16:18 EST CBL & Associates raises quarterly dividend 6.7% to 40c per share - The dividend is is payable on March 29, 2024, to shareholders of record as of March 15, 2024.
|
PRI | Hot Stocks16:17 EST Primerica raises quarterly dividend 15% to 75c per share - The dividend is payable on March 12, 2024, to stockholders of record on February 21, 2024.
|
SPG | Hot Stocks16:17 EST Simon Property authorizes $2.0B common stock repurchase program - Simon authorized a new common stock repurchase program under which the company may purchase up to $2.0B of its common stock over the next 24 months, as market conditions warrant. The program may be suspended or discontinued at any time. This new $2.0B program replaces the previous program that had been scheduled to expire on May 16, 2024 of which approximately $1.7B was available.
|
GDDY MTCH | Hot Stocks16:17 EST GoDaddy names Jared Sine as Chief Strategy & Legal Officer - GoDaddy (GDDY) will welcome Jared Sine as its Chief Strategy & Legal Officer effective March 18. Sine will assume responsibility for the Strategy, Legal, Corporate and Business Development functions. Sine will report to CEO Aman Bhutani. Before joining GoDaddy, Sine spent almost eight years at Match Group (MTCH) and served as Chief Business Affairs & Legal Officer since March 2021, overseeing privacy, safety and social advocacy, compliance, government affairs, corporate governance, general legal, aspects of corporate strategy, and mergers and acquisitions.
|
SPIR | Hot Stocks16:16 EST Signal Ocean to make $10M strategic investment in Spire Global - Spire Global and Signal Ocean have agreed to partner to drive digitization of the maritime economy. Under this agreement, Spire and Signal Ocean will partner to leverage their respective strengths. Spire will contribute its unique, proprietary datasets, relevant for precise monitoring of the maritime domain. Signal Ocean will bring its best-in-class expertise in artificial intelligence (AI), machine learning and natural language processing to create new innovative solutions to propel the digitalization of the maritime economy while enhancing global security and transparency in our oceans. On February 4, 2024, Spire and Signal Ocean Ltd entered into a securities purchase agreement for the issuance and sale of 833,333 shares of the Company's Class A common stock to Signal Ocean at a price of $12.00 per share . The Private Placement closed on February 8, 2024, resulting in gross proceeds to Spire of $10 million.
|
PETS | Hot Stocks16:16 EST PetMed Express to restate previously issued financial statements - "In preparing our 2023 Annual Report, we determined that an accrual for sales tax contingencies was required. As such, we recorded a sales tax accrual in the second and fourth quarters of fiscal year 2023 based on a determination that the sales tax liability was probable and estimable, and that such treatment was in accordance with what we believed to be the appropriate guidance from generally accepted accounting principles . In the third quarter of fiscal year 2024, the Company reviewed, in conjunction with its auditors, RSM the accounting treatment related to its previously reported sales tax accruals as well as the accounting treatment related to the deferred tax asset associated with the Company's acquisition of PetCareRx in April 2023. As a result of this review, the Audit Committee concluded, based on management's determination, that the Company incorrectly applied GAAP as it relates to the sales tax liability included in the periods contained in the Affected Financials, and that it improperly valued the deferred tax asset and goodwill reported in the first and second quarter of fiscal year 2024.The Company expects the impact of the restatement to affect multiple periods. The most significant impact to the income statement is expected to be a decrease to general and administrative expense for fiscal year 2023 in the range of $6M to $8 M and a corresponding increase in net income for the same period. This amount was originally recorded as a sales tax liability based on a probable and estimable approach, in fiscal year 2023, rather than the correct, legal liability approach, under which the sales tax liability would have been recorded for periods included in the Affected Financials. The restatement is expected to require the Company to revise and record a sales tax liability of approximately $14 to $20M as of March 31, 2020..."
|
G | Hot Stocks16:15 EST Genpact raises quarterly dividend 11% to 15.25c per share - The dividend is payable on March 26 to shareholders of record as of the close of business on March 11.
|
SYBX | Hot Stocks16:13 EST Synlogic trading halted, news pending
|
ATHA | Hot Stocks16:05 EST Athira Pharma publishes research highlighting ATH-1105 - Athira Pharma announced publication of research highlighting the neuroprotective and anti-inflammatory effects of ATH-1105 in preclinical models of amyotrophic lateral sclerosis, or ALS. The original research article was published in the peer-reviewed journal, Frontiers in Neuroscience. ATH-1105 is a next-generation, orally administered small molecule drug candidate designed to enhance the neurotrophic hepatocyte growth factor, or HGF, system. ATH-1105 enhances neurotrophic HGF system signaling and protects primary neuron cultures from various insults relevant to ALS. ATH-1105 treatment reduced astrocyte reactivity in spinal motor neuron-astrocyte co-cultures and preserved neuromuscular junction integrity in spinal motor neuron-muscle co-cultures following exposure to toxic levels of glutamate, believed to be a key driver of ALS pathology. In a TDP-43 mouse model of ALS, ATH-1105 treatment significantly preserved body weight, reduced motor and nerve function decline over time, decreased plasma biomarkers of inflammation and neurodegeneration, prevented axonal degeneration and TDP-43 pathology in peripheral nerves, and ultimately extended survival.
|
EXPE | Hot Stocks16:04 EST Expedia reports Ariane Gorin to Succeed Peter Kern as CEO - Expedia Group announced the appointment of Ariane Gorin as Expedia Group's CEO, effective as of May 13. Ms. Gorin will succeed Peter Kern, who has served as the company's CEO since 2020. After completing his contract as CEO, Mr. Kern will continue to serve as the company's Vice Chairman and member of the Board of Directors, working closely with Ms. Gorin to ensure a smooth transition. Ms. Gorin has also been elected to serve on the company's Board of Directors, Expedia stated.
|
CHDN SAP | Hot Stocks16:03 EST Churchill Downs names SAP official partner of Churchill Downs Racetrack - Churchill Downs (CHDN) announced a multi-year agreement naming SAP (SAP) an official signature partner of Churchill Downs Racetrack. SAP will be the first official technology partner serving Churchill Downs Racetrack, the Kentucky Derby, and Kentucky Oaks. The partnership also includes naming rights for the SAP Starting Gate Suites, a tower of premium, exclusive suites, and designation as the presenting partner of the Kentucky Derby and Churchill Downs mobile applications.
|
EXPE | Hot Stocks16:03 EST Expedia reports Q4 booked room nights up 9% year-over-year to 77.4M - Reports Q4 gross bookings of $21.67B, up 6% year-over-year.
|
LDOS | Hot Stocks16:02 EST Leidos, Sourcegraph announce exclusive alliance - Leidos and Sourcegraph announced an exclusive alliance to introduce secure, generative AI-enabled software development tools to government customers. Sourcegraph has spent the last ten years building its code graph, which powers Cody, the AI coding assistant for writing, fixing, and maintaining code, and Code Search, which helps developers explore their entire codebase and make large-scale migrations and security fixes. In seconds, developers can use these tools to answer technical questions, correct code, generate new code blocks, and more-no matter the code host, preferred large language model, or scale of the codebase. Leidos rapidly delivers secure software across the federal government for missions ranging from military command and control to air traffic control systems; and including critical advances in machine learning algorithms, natural language processing, computer vision and predictive analytics. Through this new alliance, Leidos and Sourcegraph plan to leverage generative AI to provide new capabilities across many markets, even for the most sensitive customer missions.
|
AGL | Hot Stocks16:00 EST Agilon Health says Benjamin Kornitzer to transition from role as CMO - Agilon Health announced that Benjamin Kornitzer, M.D., will assume a strategic role as special advisor to the company and will transition from his role as chief medical officer effective March 1, 2024. agilon health has initiated a comprehensive search process to identify a new CMO. Until a successor is named, Karthik Rao, M.D., senior medical director and vice president, network performance, will serve as interim CMO. Dr. Rao and agilon's chief clinical officer, Kevin Spencer, M.D., will co-lead the company's clinical strategy. "I want to express our deepest appreciation to Dr. Kornitzer for his leadership and considerable contributions to advancing our clinical, research and quality strategy at agilon health over the past four years. He has built a strong team, and we are glad to have him continue as a valued advisor," said Steve Sell, chief executive officer, agilon health. "I am pleased to have the support of Dr. Rao as our interim chief medical officer and Dr. Spencer who serves as our chief clinical officer, both of whom play invaluable roles working with our physician partners and advancing our Total Care Model."
|
BKKT | Hot Stocks15:11 EST Bakkt says 'management remains confident about our business' - Bakkt Holdings issued the following statement regarding the recently filed amendments to its Form 10-Q for the quarter ended September 30, 2023: "On Wednesday, we filed amendments to our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023, to provide, among other things, further updates to the description of our business and the related risk factors, including those that may result from changes in the Company's business following its acquisition of Apex Crypto LLC, now known as Bakkt Crypto Solutions, LLC. In the Amended Form 10-Q, we also included a risk factor relating to our ability to continue as a going concern 12 months following the date of the Amended Form 10-Q. Under generally accepted accounting principles, the going concern analysis can only include management's plans that have been fully implemented and are probable of occurring as of the assessment date, which excludes new products/market launches that have not been fully implemented or do not have a sufficient revenue track record. In response to questions, management remains confident about our business and will continue to focus on delivering for our clients, making progress on our primary business objectives, and working efficiently to scale our business and move toward profitability. We plan to share more during our earnings announcement later this quarter."
|
DLPN | Hot Stocks14:00 EST Street failing to appreciate Dolphin to report positive cash in 2024, CEO says
|
DLPN | Hot Stocks14:00 EST Dolphin CEO sees streaming, rise of social media as biggest changes in industry
|
DLPN | Hot Stocks14:00 EST Dolphin CEO says first phase of company's Super Group concluded
|
SGAMY... | Hot Stocks12:58 EST Sega's 'Persona 3 Reload' sells 1M copies globally in first week - Sega's (SGAMY) Atlus West said that video game "Persona 3 Reload" has sold 1M copies worldwide within its first week, becoming the fastest selling game in Atlus history. The role-playing game released February 2 for PlayStation 4 (SONY), PS5, PC, Xbox One (MSFT), and Xbox Series X/S. Reference Link
|
OXY | Hot Stocks12:31 EST Occidental Petroleum increases quarterly dividend to 22c per share - Occidental announced today its Board of Directors declared a regular quarterly dividend of 22c per share on common stock, payable on April 15, 2024, to stockholders of record as of the close of business on March 8, 2024. On an annual basis, the dividend is 88c per share at the new rate, compared to the previous annual rate of 72c per share.
|
KSCP | Hot Stocks12:25 EST Knightscope announces expansion sale of 17 K1 Call Boxes - Knightscope announces an expansion sale of 17 K1 Call Boxes using satellite communications to the Emergency Telephone Authority in Larimer County, CO, through its resale partner Stream Speed Technologies. This will be incremental to the 35 Call Boxes already installed within Larimer and Jackson Counties, providing one-touch emergency access to remote wildfire areas, hiking and camping parks.
|
LRLCY BUD | Hot Stocks12:03 EST L'Oreal says group chief corporate responsibility officer Palt to depart - L'Oreal (LRLCY) announced Wednesday the departure of Alexandra Palt from her role as Chief Corporate Responsibility Officer, effective April 1st, as she embarks on a new chapter focused on personal endeavors. Palt, who joined L'Oreal Groupe as Chief Sustainability Officer in 2013, will be succeeded as Chief Corporate Responsibility Officer by Ezgi Barcenas, who joins L'OrealGroupe from AB InBev (BUD), where she was Chief Sustainability Officer and served as a member of the senior leadership team.
|
MCY | Hot Stocks12:01 EST Mercury Insurance names Simon Zhang as chief data and analytics officer - Mercury Insurance announced that it has appointed Simon Zhang to the newly-created position of Chief Data and Analytics Officer. "This newly created position is the latest in a series of investments Mercury is making to reimagine how we use data and unlock the power of our deep data resources," said Victor Joseph, President & COO of Mercury Insurance.
|
WMS | Hot Stocks12:00 EST Advanced Drainage rises 13.3% - Advanced Drainage is up 13.3%, or $18.36 to $156.44.
|
RL | Hot Stocks12:00 EST Ralph Lauren rises 14.6% - Ralph Lauren is up 14.6%, or $21.42 to $168.56.
|
OSCR | Hot Stocks12:00 EST Oscar Health rises 28.8% - Oscar Health is up 28.8%, or $3.86 to $17.27.
|
SNDA | Hot Stocks12:00 EST Sonida Senior Living falls -11.6% - Sonida Senior Living is down -11.6%, or -$1.44 to $11.00.
|
NSP | Hot Stocks12:00 EST Insperity falls -17.8% - Insperity is down -17.8%, or -$20.13 to $92.93.
|
LSPD | Hot Stocks12:00 EST Lightspeed falls -18.6% - Lightspeed is down -18.6%, or -$3.63 to $15.94.
|
ACI | Hot Stocks11:46 EST Albertsons voluntarily recalls five ReadyMeals, store-made taco kits - Albertsons Companies has voluntarily recalled five ReadyMeals and store-made taco kits supplied by Fresh Creative Foods due to possible Listeria monocytogenes contamination. The select meals and kits contain a recalled cheese ingredient supplied by Rizo-Lopez Foods, Inc., of Modesto, California. The FDA and CDC, in collaboration with state and local partners, are investigating illnesses in a multi-year, multistate outbreak of Listeria monocytogenes infections linked to queso fresco and cotija cheeses manufactured by Rizo-Lopez Foods. Consumers who have purchased these items are urged not to consume these products and to dispose of them or return the items to their local store for a full refund.
|
UBSFY | Hot Stocks11:46 EST Ubisoft says extent of FY25 lineup to be revealed in May - The extent of the FY2024-25 line-up will be revealed in May and will notably include Assassin's Creed codename Red and Star Wars Outlaws on the premium side and The Division Resurgence and Rainbow Six Mobile on the free-to-play side.
|
CAUD | Hot Stocks11:32 EST Collective Audience appoints Joe Zawadzki as chairman of board - Collective Audience has appointed Joe Zawadzki, as chairman of its board of directors. Zawadzki currently serves as general partner at Aperiam, a venture capital and advisory firm focused on the digital transformation of marketing and media.
|
ORLY | Hot Stocks11:28 EST O'Reilly Automotive sees DIY traffic 'flat to slightly down' in 2024 - Expects to continue to gain share to partially offset the normal industry drag on ticket. Comments taken from Q4 earnings conference call.
|
ARRW | Hot Stocks11:25 EST Arrowroot Acquisition Corp trading resumes
|
ARRW | Hot Stocks11:20 EST Arrowroot Acquisition Corp trading halted, volatility trading pause
|
MAT | Hot Stocks11:02 EST Mattel appoints Christopher Farrell as EVP and Chief Strategy Officer - Mattel announced that Christopher Farrell has joined the company as Executive Vice President and Chief Strategy Officer, effective immediately. Farrell will lead strategic planning and corporate development for the company, including identifying opportunities to accelerate growth and profitability and optimize business performance. He will report to Ynon Kreiz, Chairman and CEO of Mattel. Farrell joins Mattel from Ahold Delhaize, the Dutch multinational food retailer with operations in the U.S., Europe and Asia, where he was Global Head of M&A for the last five years.
|
HSBC... | Hot Stocks10:41 EST HSBC, Google Cloud partner to grow climate tech ecosystem - HSBC (HSBC) announced a partnership with Google Cloud (GOOG) to accelerate climate mitigation and resilience through financing and support for companies in the Google Cloud Ready - Sustainability programme. GCR-Sustainability is a validation programme for companies with solutions available on Google Cloud that help customers achieve goals including carbon emission reduction, increased sustainability in value chains, and processing of ESG data to help identify climate risks. Under the new partnership, Google Cloud will introduce GCR-Sustainability companies to HSBC's specialist climate tech finance team to explore venture debt financing options. Key goals of the partnership include: Google Cloud will continue to increase the number of partners in the GCR - Sustainability programme over the next two years. HSBC will seek financing opportunities for companies within the GCR-Sustainability ecosystem, as part of its ambition to deploy $1bn of climate tech finance, as well as facilitating connections with HSBC's customer base.
|
SNDA | Hot Stocks10:40 EST Sonida Senior Living Inc trading resumes
|
SNDA | Hot Stocks10:35 EST Sonida Senior Living Inc trading halted, volatility trading pause
|
QTWO | Hot Stocks10:13 EST Wave selects Q2 Holdings for digital receipt management solutions - Q2 Holdings announced Wave has selected Q2 as its strategic digital partner to offer its customers a streamlined and intuitive approach to managing expenses while gaining deeper insights into financial data. Q2 Spend Manager enables small and medium-sized businesses to automate and streamline expense management, resolving the cumbersome and error-prone process of tracking expenses. The partnership will enable Wave to help its clients reduce the burden of manual expense tracking, improve accuracy and provide a real-time view of financial transactions.
|
RMR | Hot Stocks10:11 EST RMR Group sees earnings accretion from RMR Residential starting in 2H
|
RMR | Hot Stocks10:03 EST RMR: Entering generally more favorable environment for commercial real estate
|
RMR | Hot Stocks10:03 EST RMR Group: Commercial real estate under pressure - Currently seeing positive signs as U.S. economy continues to perform well. Comments taken from Q1 earnings conference call.
|
ERF DVN | Hot Stocks10:02 EST Enerplus up 7% after Reuters report of Devon takeover approach
|
GEHC | Hot Stocks10:01 EST GE HealthCare, Medquest enter three-year collaboration - GE HealthCare and MedQuest Associates announced a three-year collaboration to deliver excellence in patient care by providing access to innovative technologies from GE HealthCare and the infrastructure and resources from MedQuest that are needed to optimize multi-site outpatient imaging networks for success. . MedQuest's model of joint ventures with health systems, coupled with GE HealthCare's innovative technologies, will help deploy emerging imaging solutions, including solutions to support Theranostics, into the ambulatory setting.
|
BDC | Hot Stocks10:00 EST Belden rises 11.2% - Belden is up 11.2%, or $8.32 to $82.82.
|
WMS | Hot Stocks10:00 EST Advanced Drainage rises 15.2% - Advanced Drainage is up 15.2%, or $21.02 to $159.10.
|
OSCR | Hot Stocks10:00 EST Oscar Health rises 20.4% - Oscar Health is up 20.4%, or $2.74 to $16.15.
|
CMP | Hot Stocks10:00 EST Compass Minerals falls -13.1% - Compass Minerals is down -13.1%, or -$2.95 to $19.61.
|
NSP | Hot Stocks10:00 EST Insperity falls -17.5% - Insperity is down -17.5%, or -$19.76 to $93.30.
|
LSPD | Hot Stocks10:00 EST Lightspeed falls -18.0% - Lightspeed is down -18.0%, or -$3.53 to $16.04.
|
FRFHF | Hot Stocks09:52 EST Fairfax Financial 'disagrees' with Muddy Waters report - "Earlier, Muddy Waters Research issued a report regarding Fairfax Financial Holdings suggesting that the book value of Fairfax was overstated. Fairfax disagrees with the allegations and insinuations contained in the report, and would like to assure all shareholders that Fairfax has prepared its financial statements and reporting in accordance with all applicable accounting principles. Through the first nine months of 2023, Fairfax has achieved record earnings driven by record operating income. Fairfax will release its fourth quarter and year-end financial results next Thursday, February 15, 2024, and a conference call will follow on the morning of Friday, February 16, 2024, and the management of the company is pleased to address any questions relating to those results or the report issued today at that time."
|
CMP | Hot Stocks09:47 EST Compass Minerals falls -11.2% - Compass Minerals is down -11.2%, or -$2.53 to $20.03.
|
NSP | Hot Stocks09:47 EST Insperity falls -11.5% - Insperity is down -11.5%, or -$12.99 to $100.06.
|
LSPD | Hot Stocks09:47 EST Lightspeed falls -22.9% - Lightspeed is down -22.9%, or -$4.49 to $15.08.
|
TAL | Hot Stocks09:47 EST TAL Education rises 9.1% - TAL Education is up 9.1%, or $1.09 to $13.13.
|
RL | Hot Stocks09:47 EST Ralph Lauren rises 11.4% - Ralph Lauren is up 11.4%, or $16.76 to $163.90.
|
OSCR | Hot Stocks09:47 EST Oscar Health rises 25.5% - Oscar Health is up 25.5%, or $3.42 to $16.83.
|
CART | Hot Stocks09:42 EST Hy-Vee, Instacart announce expanded partnership agreement - Hy-Vee announced it has expanded its partnership with Instacart. Powered by Instacart Fulfillment as a Service, Hy-Vee is integrating Instacart's fulfillment capabilities for same-day delivery into its owned and operated websites and apps. "We're proud to strengthen our partnership with Hy-Vee and equip them with the technology and tools they need to meet customers' needs," said Ryan Hamburger, Vice President of Retail Partnerships at Instacart. Hy-Vee and Instacart first partnered in 2018 when they introduced same-day delivery to Hy-Vee customers for the first time through the Instacart App.
|
BKSY | Hot Stocks09:41 EST BlackSky wins $50M in multiyear contracts for Gen-3 capabilities - BlackSky Technology announced that it won a first-of-its-kind contract with Thales Alenia Space supporting the Ministry of Defense of the Republic of Indonesia to deliver Gen-3 Earth observation satellites, ground station capabilities and flight operations support. BlackSky has also provided Assured subscription-based real-time imagery and analytics services to support the Indonesian MoD. These multi-year contracts have a combined value of approximately $50M. "Continuing our string of pioneering innovations in the space-based intelligence industry, BlackSky now offers sovereign nations the ability to gain foresight into critical matters that affect their national security and economy using commercially available Earth observation technology today," said Brian E. O'Toole, BlackSky CEO.
|
TTNP | Hot Stocks09:40 EST Titan Pharmaceuticals trading resumes
|
ZJYL | Hot Stocks09:39 EST Jin Medical International Ltd trading resumes
|
FBLG | Hot Stocks09:39 EST Fibrobiologics Inc. trading resumes
|
K | Hot Stocks09:35 EST Kellanova: Could take a couple of quarters before negative industry trends abate - Comments taken from Q4 earnings conference call.
|
HOLO | Hot Stocks09:35 EST MicroCloud Hologram Inc trading resumes
|
ZJYL | Hot Stocks09:34 EST Jin Medical International Ltd trading halted, volatility trading pause
|
FBLG | Hot Stocks09:34 EST Fibrobiologics Inc. trading halted, volatility trading pause
|
VZ ERIC | Hot Stocks09:33 EST Verizon, Vonage collaborate to bring advanced 5G network APIs to developers - Verizon (VZ) and Vonage, a part of Ericsson (ERIC), have entered into a memorandum of understanding outlining their intention to introduce Verizon network Application Programming Interfaces to the Vonage platform that will enable the developer community to access network services and capabilities. The companies will also collaborate in developing new APIs, an important step in creating an ecosystem of network APIs that can be leveraged by developers to build secure, reliable and innovative applications. The plan to integrate the Verizon network services into Vonage's platform will enable enterprises to create deeper engagement with consumers across the customer journey to drive a better overall experience and brand loyalty. The collaboration will build on existing APIs to innovate on next generation, advanced APIs that will drive the global industry forward towards easy, ubiquitous access to cutting-edge network capabilities. This is essential to unleash the full potential of the 5G network, speed digital transformation within enterprises and create incremental monetization of network assets.
|
AVAV | Hot Stocks09:32 EST AeroVironment awarded $2.67M DoD contract - AeroVironment's Tomahawk product line has been awarded a $2.67M contract from Advanced Technology International, or ATI, that will be managed by the U.S. Marine Corps Warfighting Lab, or MCWL. This contract supports the Marine Corps' Force Design 2030 and other DoD initiatives of enhancing lethality and mission success across the warfighting functions.
|
SBEV | Hot Stocks09:32 EST Splash Beverage enters distribution partnership with Armada Distributing - Splash Beverage Group announced its distribution partnership with Armada Distributing. The collaboration with Armada Distributing marks a significant expansion of Splash's brands distribution footprint, specifically covering the entire state of Oklahoma. With a dedicated team of 25 salespeople, Armada Distributing brings unparalleled expertise and market knowledge to the partnership, positioning Copa di Vino, SALT Tequila, Pulpoloco and TapouT for growth and increased market penetration in the region. The launch of this partnership is slated to occur here in the first quarter of 2024, and adds strong support to our 2024 growth plans. Leveraging Armada Distributing's extensive reach in the state and dedicated sales force, Splash anticipates ready access for its brands into retail and on-premise outlets across Oklahoma, ultimately enhancing brand visibility and driving consumer engagement.
|
HOLO | Hot Stocks09:30 EST MicroCloud Hologram Inc trading halted, volatility trading pause
|
TTNP | Hot Stocks09:30 EST Titan Pharmaceuticals trading halted, volatility trading pause
|
K | Hot Stocks09:27 EST Kellanova accelerating 15% medium-term operating profit margin target to 2026 - Comments taken from Q4 earnings conference call presentation slides.
|
HLF | Hot Stocks09:25 EST Herbalife launches GLP-1 nutrition companion product combos - Herbalife earlier announced the launch of the Herbalife GLP-1 Nutrition Companion, a new range of food and supplement product combos fueled by the company's protein shake and intended to support the nutritional needs of individuals on GLP-1 and other weight-loss medications. Herbalife's Classic and Vegan options are now available in the United States and Puerto Rico in a variety of flavors, the company said. "Weight-loss drugs curb your appetite, so people taking medications like GLP-1 Agonist may have difficulty getting all the macronutrients, micronutrients or physical activity they need for optimal muscular, cardiovascular and brain health," said Kent Bradley, M.D., MBA, MPH, chief health and nutrition officer at Herbalife. "Individuals taking these medications should supplement with products that help meet these needs and focus on making foundational lifestyle changes to achieve sustainable weight loss.
|
CRKN | Hot Stocks09:20 EST Crown Electrokinetics appoints Corey Boaz as president, construction - Crown Electrokinetics Corp. announced that it has named Corey Boaz as President of Construction of its fiber optics division, Crown Fiber Optics.Through his consulting firm, Mr. Boaz has worked closely with several of the largest corporations in the oil and gas, renewables, telecommunications, and heavy civil construction sectors.
|
WKEY | Hot Stocks09:19 EST WISeKey expands WISeSat.Space 2024 Strategy - WISeKey International unveiled a significant expansion of its WISeSat.Space strategy for 2024. WISeSat.Space is a subsidiary of WISeKey, revolutionizing IoT connectivity with the first cost-effective and secure solution, leveraging picosatellites and low-power sensors to provide unparalleled IoT connectivity across the globe. The strategic expansion includes the scheduled launch of new satellites in the fourth quarter of 2024, alongside the introduction of groundbreaking technology aboard its latest generation of Low Earth Orbit satellites. This initiative is designed to meet the extensive IoT deployment needs across various sectors, including Smart Farming, Energy, and Logistics, ensuring reliable and secure data transmission anywhere on Earth. To date, seventeen satellites equipped with WISeSat technology have been launched into orbit aboard SpaceX rockets, marking the initial phase of a visionary plan to deploy an 80-satellite constellation. This network aspires to provide comprehensive global IoT connectivity with an impressive data latency goal of just 10 hours. In anticipation of the emerging quantum computing era, WISeSat.Space is proactively enhancing its security measures. The company is pioneering the adoption of post-quantum cryptographic solutions and devices provided by SEALSQ, WISeKey's semiconductor subsidiary, thereby establishing new benchmarks for secure multi-factor authentication and the protection of critical data exchanges in the quantum future.
|
ABVC | Hot Stocks09:18 EST ABVC BioPharma acquires $2.96M worth of land in Asia - ABVC BioPharma signed a definitive agreement to acquire real estate in Taoyuan City, Taiwan. The acquisition of real estate assets, estimated at approximately $2.96 million via an equity transfer of $3.50 per share, is to develop plant factories for ABVC's botanical pipeline strategically; ABVC hopes the property will ultimately be used as an integrated platform for the global development of the Asian healthcare business and the medical, pharmaceutical, and biotechnology industries. The acquisition aims to establish a base for Good Agricultural Practices (GAP) fields and an integrated platform for collaboration between researchers and industry leaders. ABVC will issue the current landowner shares of ABVC common stock at $3.50 per share and a warrant to purchase up to 1,000,000 shares of common stock in consideration for ownership of the property, which is estimated at $2.96 million by a third-party valuation company. This is a related party transaction since the seller is one of ABVC's directors who owns approximately 10% of ABVC's issued and outstanding shares of common stock and is married to ABVC's Chief Strategic Officer.
|
NOK | Hot Stocks09:17 EST Nokia concludes smartphone patent license renewal cycle - Nokia has signed its last remaining major smartphone patent license agreement and concluded its smartphone patent licence renewal cycle which began in 2021. Nokia Technologies - Nokia's licensing business - will now enter a period of stability with no major smartphone agreements expiring for a number of years. The announcement follows recent agreements with Honor, OPPO, vivo, and the new agreement now concluded with a company whose license expired earlier, as well as the license agreements signed with Apple and Samsung last year, and Huawei in December 2022. As a result, Nokia Technologies currently has an annual net sales run-rate of approximately EUR 1.3 billion, excluding catch-up net sales. In addition to the remaining addressable smartphone market, it will continue to focus on opportunities to grow the annual net sales run-rate through patent licensing in areas such as automotive, consumer electronics, IoT and multimedia, to reach a run-rate of EUR 1.4-1.5 billion in the mid-term. Considering the many agreements Nokia Technologies has signed in the quarter, its Q1 net sales are expected to benefit from significant catch-up net sales in excess of EUR 400 million related to prior periods of non-payment. This is consistent with the assumption that Nokia provided in its Financial Report for Q4 and Full Year 2023 for Nokia Technologies to generate at least EUR 1.4 billion of operating profit in 2024 including the benefit of catch up net sales.
|
AGS | Hot Stocks09:15 EST PlayAGS partners with EQL Games - PlayAGS announced a partnership with EQL Games. AGSi, AGS' Interactive division, will partner with EQL Games to provide its robust library of unique and engaging real-money online games to U.S. and Canadian iLottery players. The aggregation deal, which was consummated at ICE London 2024, strategically expands the reach of AGS' high-performing online content catalog to the growing North American iLottery market. Through EQL Games' iLottery aggregator, AGSi will introduce proven game titles like Mega Diamond, Rakin' Bacon Deluxe and Capital Gains to the lottery market and develop new titles built specifically for the iLottery player.
|
SLI | Hot Stocks09:14 EST Standard Lithium reports cash, equivalents totaling C$15.8M - "In 2023, the lithium sector has been under pressure, with lithium prices experiencing a significant decrease from the all-time highs seen in 2022, a situation compounded by the prevailing interest rate environment and other macroeconomic factors," says Robert Mintak, CEO and Director of Standard Lithium. "Despite the industry-wide market challenge, the long-term fundamentals for lithium continue to be strong, particularly for projects situated in geopolitically stable regions such as the United States, where policy support and other key strategic advantages are enabling for project differentiation. The Smackover region, in particular, is attracting interest from major players in the global energy sector. Discussions around strategic partnerships, joint development opportunities, and long-term off-take are robust and moving forward. In response to these market dynamics, we are taking responsible and appropriate actions that are in the best interests of our shareholders, ensuring that Standard Lithium remains well-positioned to capitalize on what continues to be an exciting sector with extraordinary growth prospects." Cash and equivalents and working capital of Ca$15.8 million and Ca$5.7 million, respectively, as of second fiscal quarter end, and in combination with the prudent and strategic use of our at-the-market offering program as a tool to fund any short term financing needs, are expected to sustain the Company through the 2024 fiscal year.
|
GV | Hot Stocks09:12 EST Visionary Holdings CEO Fan Zhou resigns, Rusheng Wu to succeed - Visionary Holdings announced that Fan Zhou notified Visionary Holdings of her resignation as its CEO and chairperson, effective on February 6. The company's board of directors elected William Chai as the company's Chairman of the Board of Directors to succeed Fan Zhou. Additionally, the Board elected Rusheng Wu as the company's CEO. Zhou will remain as a director of the company. Chai joined the Board as an independent director on November 22, 2022 and will continue to serve as a member and chairman of the Audit Committee, and as a member to both the Nominating and Corporate Governance Committee and Compensation Committee. Wu possesses 25 years of education management across high school, college and online learning. Since June 2016, he has held leadership roles at Toronto eSchool, including Director and Vice President.
|
INDI AVT | Hot Stocks09:11 EST Avnet and indie Semiconductor enter global distribution agreement - indie Semiconductor (INDI), and Avnet (AVT) a global technology distributor, have executed a distribution agreement to accelerate global availability of indie's innovative semiconductor product portfolio, leveraging Avnet's extensive market reach, support, and fulfillment capabilities. "indie is excited to partner with Avnet to bring our world-class automotive portfolio to a global customer base," said Michael Wittmann, chief operating officer at indie Semiconductor. "Avnet's strong expertise in the automotive segment, coupled with its global reach, will allow our class-leading products to bring value to customers across global automotive development regions." "We look forward to collaborating closely with indie to bring Avnet's global support network and market knowledge to indie's broad and differentiated automotive portfolio to help meet the innovation needs of a fast-evolving industry," said Mat Ransom, global vice president Automotive and ASCS, Avnet.
|
PLBC | Hot Stocks09:10 EST Plumas Bancorp appoints Patel to board of directors - The directors of Plumas Bancorp announces the appointment of Sushil Patel to the Plumas Bancorp and Plumas Bank Board of Directors. Patel is owner of Laxmi Hotels and managing partner at Mountain West Builders.
|
SGD | Hot Stocks09:10 EST Safe and Green Development acquires XENE Real Estate AI software - Safe and Green Development announced that it has closed on the previously announced acquisition of Majestic World Holdings, a real estate technology firm and owner of the Xene AI Software platform. The purchase price for the acquisition consists of an aggregate of $500 thousand in cash to be paid over 5 quarters and 500,000 shares of SG Devco restricted stock valued at $1.075 million, or $2.15 per share. Under the terms of the agreement, Matthew Barstow, MWH CEO & President will become Senior Vice President of Innovation at SG Devco. The acquisition is a milestone in the company's short history and adds a new vertical to the SG DevCo portfolio. The addition of MWH diversifies SG DevCo's business interests and adds a new source of potential revenue. David Villarreal, President & CEO of Safe and Green Development Corporation, stated, "Majestic is an innovator in real estate technology with a unique asset base and people with deep industry knowledge. The combined capabilities of our two companies is expected to provide long-term value creation well in excess of what either company was capable of doing on a individually. We believe this transaction will immediately and in the long-term drive significant value to our shareholders."
|
HLIO | Hot Stocks09:09 EST Helios: Facilities for North America hydraulics segment functional since Q4 - Helios Technologies is pleased to announce that both Regional Operational Centers of Excellence for its Hydraulics segment in North America have been fully operational since the fourth quarter of 2023...serveing as the hub for manifold machining and integrated package assembly operations, consolidating operations from Sun Hydraulics, Faster Inc., and Daman Products into a North American center for integrated hydraulics solutions. Schultes Precision Manufacturing provides enhanced support for diversified machining and aided with the machining of manifolds during the transition. The Hydraulic Manifold Solutions CoE has reached strong throughput levels supporting approximately $100 million in run-rate annual revenues, up from approximately $30 million from one year ago and allows for future growth.
|
LQR | Hot Stocks09:09 EST LQR House joins Webull's Corporate Connect Service - LQR House has begun participating on the Webull Corporate Connect Service . This strategic move is aimed at fostering transparency and strengthening connections with shareholders.
|
MTTR | Hot Stocks09:09 EST Matterport, Visiting Media announce multi-year agreement - Matterport announced an agreement with Visiting Media. With this new agreement, Visiting Media deepens its use of Matterport's Digital Twin Platform and Property Marketing solution as the 3D technology of choice for the thousands of hotels it supports. In collaboration for years, Visiting Media has amplified the application of Matterport's digital twins for virtual tours of more than 17,000 spaces. With this extension of virtual tour capabilities, hospitality revenue teams can save daily hours by streamlining multiple workflows across their properties while supporting above-property teams and enhancing channel distribution capabilities. This new agreement highlights the powerful application of these technologies, working better together for the unique needs of hospitality sales and marketing teams.
|
NVVE | Hot Stocks09:08 EST Nuvve Holding back in compliance with Nasdaq minimum bid price rule - Nuvve Holding it is back in compliance with the Nasdaq minimum bid price rule. On February 5, the company received a letter from Nasdaq notifying the company that it had regained compliance with Nasdaq because for the last 10 consecutive business days, from January 22, 2023, through February 2, 2024, the closing bid price of the company's Common Stock had been at $1.00 per share or greater. Accordingly, the company has regained compliance with Nasdaq Listing Rules and Nasdaq considers this matter closed.
|
WRAP | Hot Stocks09:07 EST Wrap Technologies announces deployment of BolaWrap for Fairfax County PD - Wrap Technologies announces a significant milestone in its commitment to public safety with the full deployment of the BolaWrap Remote Restraint device for the Fairfax County Police Department in Fairfax, Virginia. This marks one of the first full deployments of this groundbreaking technology by a major law enforcement agency in the United States. The decision to implement BolaWrap devices department-wide follows a successful pilot program conducted by FCPD. This full-scale deployment by the FCPD is a significant stride towards creating a safer environment for both officers and the communities they serve. BolaWrap's utility extends far beyond traditional law enforcement practices, providing a humane and effective response to incidents involving individuals in crisis.
|
SNES | Hot Stocks09:06 EST SenesTech signs distribution agreement for Evolve in Australia, New Zealand - SenesTech entered into a Distribution Agreement for Evolve Soft Bait with Evicom, an environmental management firm based in Australia with distribution throughout Australia, New Zealand and the surrounding region. The agreement with Evicom includes annual minimums, and that Evicom will take the lead on regulatory approvals.
|
MGM | Hot Stocks09:06 EST BetMGM reports FY23 revenue up 36% to $1.96B - BetMGM delivered a strong FY 2023 financial performance. Net revenue from operations grew 36% year over year to $1.96 B, at the upper-end of $1.8B-$2B guidance range. Same-state growth in net revenue from digital operations of 14%. Key metrics across both iGaming and Online Sports Betting improved year over year, including average monthly actives, FTDs, hold percentages, bonus levels, NGR per active, and CPAs. EBITDA positive in the second half of 2023 with expected FY 2023 EBITDA loss of approximately $67M. Reiterating guidance from December 2023 business update of targeting approximately $500M of EBITDA in 2026.
|
INUV | Hot Stocks09:06 EST Inuvo spotlights customizable AI capabilities for precision marketing - Inuvo spotlights its purpose-built customizable AI capabilities that enable marketers to generate custom IntentKey audience models based on their own proprietary strategies, products, and market insights. IntentKey's capabilities are especially significant in 2024, as Apple and Google continue their online privacy mission, with Google announcing their target to go 100% cookie-free by the end of the year. IntentKey doesn't depend on cookies to source information and allows brands to gather data without compromising audiences' privacy. While large-language model chatbots, like ChatGPT from OpenAI and Google Bard, have sparked excitement around customizability and problem solving, Inuvo has focused on the adaptability of its AI specifically for modeling audiences for advertising. IntentKey is the first and only LLM built from the ground up to generate and target audiences - no two IntentKey client models are alike.
|
CVKD | Hot Stocks09:03 EST Cadrenal Therapeutics names Jeff Cole as COO - Cadrenal Therapeutics announced the appointment of Jeff Cole to the newly created position of COO. In this role, Cole will be responsible for the company's manufacturing and supply chain operations, intellectual property, commercialization strategies, and supporting partnering activities for tecarfarin. Cole brings over 25 years of experience in global pharmaceutical manufacturing and commercial operations, finance, and corporate development to the company. This includes senior executive roles at both private and publicly-traded companies such as Espero BioPharma, Valeant Pharmaceuticals International, and Legacy Pharmaceuticals.
|
SPT | Hot Stocks09:03 EST Sprout Social expands partnership with Reddit - Sprout Social announced it entered into an enhanced partnership with Reddit, where Sprout users will gain access to deeper and more valuable real-time Reddit data for insights into public conversations and customer activity along with brand and industry trends. "Reddit has always been a central community for a wide and diverse range of conversations and we've seen it have an increased impact on brand outcomes in recent years," said Justyn Howard, CEO of Sprout Social. "As social insights become essential to remaining competitive and driving innovation across an organization, this expanded offering will provide increased value to our users and their understanding of their businesses and customers."
|
NEXN | Hot Stocks09:02 EST Nexxen announces expansion of partnership with TCL FFALCON - Nexxen announced the expansion of its strategic partnership with TCL FFALCON, a global leading Internet and AIxIoT service platform. This expansion not only designates Nexxen's supply-side platform as TCL's preferred supply platform partner, but also grants Nexxen SSP the opportunity to exclusively sell TCL's native display inventory, solidifying both companies' commitment to providing advertisers with opportunities to reach highly engaged audiences across screens globally. "We are thrilled to deepen our partnership with TCL FFALCON," said Kenneth Suh, Chief Strategy Officer at Nexxen. "This enhanced relationship not only positions Nexxen SSP as TCL's preferred supply partner, but also opens up exciting avenues for advertisers seeking to harness the potential of TCL's native display inventory. Together, we are dedicated to driving unique value and engagement for them globally."
|
UA UAA | Hot Stocks08:59 EST Under Armour says China was leading contributor to Q3 growth - Says inconsistency has permeated U.S. business. Says on right path to addressing these inconsistencies. Says footwear is most significant growth opportunity. Says UA rewards is a bright spot and has hit 3M members. Says China was leading contributor to Q3 growth. Says maintaining cautious view of the market. Comments taken from Q3 earnings conference call.
|
IDT | Hot Stocks08:59 EST net2phone launches Global Connect service - net2phone launched its Global Connect service. Global Connect provides multinational businesses with a single-channel, enterprise-grade cloud connectivity solution across multiple geographies. Organizations utilizing SIP trunks to connect their net2phone UContact CCaaS service, Microsoft Teams, or legacy on-premise PBX platforms, can now shed their costly local voice connectivity services.
|
KOPN | Hot Stocks08:58 EST Kopin gets order from Naval Air Warfare Center for advanced microdisplay - Kopin Corporation announced the award of a new Small Business Innovation Research SBIR contract from the Naval Air Warfare Center. Under the terms of the contract, Kopin will leverage over 30 years of expertise in US-based microdisplay development to deliver advanced microdisplays for lensless computational imaging. The goal of the research is to develop a high-resolution microdisplay which can operate at very high framerates to support development of trusted AI and autonomous capabilities for computational imaging. Kopin intends to accomplish this objective by introducing enhancements to existing microdisplay designs to achieve the performance requirements of this program. The expected output is a microscale , high-resolution display and drive board with transparent and back-lit versions. "This is the first award to Kopin by the Navy for research that advances vision technology in a very novel way," stated Bill Maffucci, the Company's Senior Vice President of Business Development and Strategy. "Kopin intends to work with the Office of Naval Research to develop through this program a range of lensless, optical-computing devices that provide new capabilities in the areas of computer vision and computational imaging."
|
AIM | Hot Stocks08:53 EST AIM ImmunoTech reports topline results from Phase 2 study of Ampligen - AIM ImmunoTech announced topline results from the Company's Phase 2 study evaluating the efficacy and safety of Ampligen as a potential therapeutic for people with the Post-COVID condition of fatigue. The AMP-518 clinical trial was a two-arm, randomized, double-blind, placebo-controlled, multicenter study. The primary outcome measure is change from baseline to week 13 in PROMIS Fatigue Score. Although the reduction in that measure did not show a significant difference at the 13-week time point, initial analysis revealed that subjects in the Ampligen group had experienced lower levels of fatigue at multiple time points during the treatment phase when compared to the placebo group. An analysis of secondary and ad hoc endpoints found that the difference in change from baseline in PROMIS Fatigue Score between the Ampligen and placebo groups reached or approached statistical significance at several timepoints during the treatment phase. The Six-Minute Walk Test also revealed a higher impact of Ampligen on distance traveled in six minutes at Week 13 compared to placebo. Eighty subjects were enrolled in AMP-518, and forty were randomized to each treatment group. Of the 80 enrolled subjects, 66 subjects completed the treatment, which consisted of 36 subjects in the Ampligen group and 30 subjects in the placebo group. The primary reasons for discontinuation from treatment included withdrawal by subject, lost to follow-up, and adverse event. Demographics and baseline characteristics were generally comparable between the Ampligen and placebo groups. Additionally, the analysis of safety parameters demonstrated that Ampligen was generally well-tolerated with no severe adverse events, no treatment-emergent adverse events leading to death, and no severe TEAEs reported during the study. There were six subjects in the Ampligen group with TEAEs considered related to the study treatment, the majority of which were mild in severity. Two subjects in the Ampligen group had TEAEs leading to treatment discontinuation or interruption. More subjects in the Ampligen group compared to the placebo group reported TEAE, however the majority of these were mild.
|
TPR | Hot Stocks08:46 EST Tapestry sees mid-single digit sales growth in China for FY
|
TPR | Hot Stocks08:46 EST Tapestry 'unsatisfied' with recovery of Stuart Weitzman - Comments taken from Q2 earnings conference call.
|
MDU | Hot Stocks08:38 EST MDU Resources provides 2024 guidance - For 2024, MDU Resources expects earnings from its regulated energy delivery businesses of $170M-$180M, construction services revenues of $2.9B-$3.1B, with margins comparable to 2023, and EBITDA of $220M-$240M.
|
CNM | Hot Stocks08:37 EST Core & Main names Stephen LeClair as the new chairman, CD&R sells remainin stake - Core & Main announced that its board of directors has elected Stephen O. LeClair as the new chairman of the board, effective immediately. LeClair will continue serving as chief executive officer of Core & Main. James G. Castellano will serve as lead independent director, in addition to his responsibilities as the audit committee chair, and Kathleen M. Mazzarella will serve as chair of the nominating and governance committee. In addition to these changes, James G. Berges, Nathan L. Sleeper, Jonathan L. Zrebiec and Ian A. Rorick, all affiliates of Clayton, Dubilier & Rice or CD&R , have resigned from Core & Main's board after serving since 2017, when CD&R assumed a majority stake in Core & Main. CD&R sold its remaining stake in Core & Main in January 2024.
|
GM TSLA | Hot Stocks08:37 EST General Motors hires former Tesla executive Kurt Kelty as VP of Batteries - General Motors (GM) says the company "continues to invest in the infrastructure and attract world-class talent to make that a reality," reporting that GM has hired Kurt Kelty, a "globally recognized battery expert" and former Tesla (TSLA) executive, to be vice president of Batteries, reporting to GM President Mark Reuss. "In this newly created role, Kelty will be charged with GM's battery cell strategy and a new end-to-end approach. This will include the use of raw materials, research, developing and investing in new technology, commercialization of cells and packs, and end of life opportunities. His team will be responsible for a critical piece of GM's electrification strategy, bringing together the company's already robust battery development resources with industry expertise to more quickly deliver profitable, lower-cost, higher performing electric vehicles to customers at scale," GM stated. Reference Link
|
SPCB | Hot Stocks08:36 EST SuperCom announces new EM contract in California - SuperCom is excited to announce it has secured a new contract with an established California services provider in the judicial sector. This contract, already operational and generating revenue, is particularly notable for SuperCom's successful displacement of a long-time incumbent competitor, primarily due to its new innovative PureOne solution. This strategic collaboration aligns with SuperCom's vision of expanding its footprint in the US market and demonstrates its competitive edge in delivering superior technology solutions. The contract terms, underpinned by a recurring lease model, reflect expansion and long-term growth potential. This partnership with a new customer highlights SuperCom's ability to forge new, valuable relationships in the US. The open-ended nature of the contract offers substantial opportunities for scaling and long-term collaboration, indicating both the resilience and adaptability of SuperCom's business model.
|
BRSH | Hot Stocks08:35 EST Arrive partners with AllMart to launch smart mailbox solution in Antigua - Arrive Technology announced that it has signed an agreement with AllMart Marketplace to initially deploy up to 25 Arrive smart mailboxes to facilitate secure deliveries on the island nation of Antigua. This announcement comes on the heels of Arrive's previously announced agreement and plan of merger with Bruush Oral Care. Arrive CEO Dan O'Toole said the deployment of Arrive mailboxes in Antigua results from Arrive's recent acquisition of Airbox Technologies and its patent portfolio. Airbox had a pre-existing relationship with AllMart but had yet to begin facilitating deliveries. "We acquired Airbox to enhance our own, first-position patent portfolio but also to speed up our deployment plans," O'Toole said. "Moderate regulations and more open skies make Antigua an ideal testing ground and will quickly demonstrate to the world how our Mailbox-as-a-Service platform and autonomous delivery will transform the last mile of package delivery."
|
SIDU | Hot Stocks08:35 EST Sidus Space appoints Bill White CFO, effective February 20 - Sidus Space announced the appointment of Bill White as Chief Financial Officer, effective February 20 Mr. White will oversee the Company's accounting, financial planning, capital raise, treasury, legal and regulatory functions. Mr. White has more than 30 years of experience in financial management, operations, and business development. He most recently served as Chief Financial Officer of ProPhase Labs, Inc. (Nasdaq: PRPH) and prior to ProPhase he was CFO, treasurer, and secretary of Intellicheck, Inc., a technology company listed on the NasdaqGM. Mr. White has broad domestic and international experience including managing rapid and significant growth, import/export, implementing tough cost management initiatives, exploiting new growth opportunities, mergers and acquisitions, strategic planning, resource allocation, tax compliance and organization development.
|
RXT DBD | Hot Stocks08:34 EST Rackspace Technology appoints Gross to board of directors - Rackspace Technology (RXT) announced the appointment of Mark Gross to its Board of Directors. Gross is an experienced and dynamic leader with over 25 years of broad-based experience, financial expertise, and deep insight into leading business transformations. Gross succeeds Thomas Cole, who unexpectedly passed away over the recent holiday season. Gross is an experienced board member and currently serves as a board member and governance committee chair at Diebold-Nixdorf (DBD), a global provider of banking and retail technology systems.
|
SBET | Hot Stocks08:34 EST SharpLink Gaming regains full compliance with Nasdaq listing standards - SharpLink Gaming received formal notification from the Nasdaq Stock Market that its deficiency under Listing rule 5550(b) has been cured, and that the Company is back in compliance with all applicable continued listing standards. As a result, the hearing before the Nasdaq Listing Qualifications Panel, originally scheduled for February 20, 2024, has been cancelled; and SharpLink's ordinary shares will continue to be listed and traded on Nasdaq.
|
OMH | Hot Stocks08:33 EST Ohmyhome announces growth updates since acquisition of Simply Sakal - Ohmyhome announces significant developments and milestones following its acquisition of Simply Sakal Pte. Ltd. Simply Sakal Pte. is now renamed as Ohmyhome Property Management further enhancing the one-stop brand of Ohmyhome. This strategic transaction has not only expanded Ohmyhome's service offerings to include a non-cyclical recurring revenue stream, but also established a strong position in the condominium property management sector in Singapore with close to 6,800 units under management and an ARR reaching $2.7 million on December 31, 2023. The condominiums are across various districts in Singapore with sizes ranging from 10 to over 700 units per project. The property management business has historically grown its business at 57% CAGR, achieving revenue of $2.0 million in 2022 with 4,648 units under management.
|
WBA | Hot Stocks08:32 EST Walgreens Boots Alliance appoints Elizabeth Burger as CHRO - Walgreens Boots Alliance CEO Tim Wentworth announced updates to WBA's executive committee. Elizabeth Burger has been appointed executive vice president and chief human resources officer, or CHRO. Prior to joining WBA, Burger served as senior vice president, CHRO at Flowserve.
|
NXL | Hot Stocks08:32 EST Nexalin announces regulatory approval in Oman for neurostimulation device - Nexalin Technology has been granted regulatory approval by the Sultanate of Oman's Ministry of Health. Mark White, CEO of Nexalin Technology, stated, "We are pleased to announce the approval to sell our Gen-2 neurostimulation device in Oman, which represents our first regulatory approval outside of China. Not only is Oman an important gateway to the Middle East, but we intend to seek, and expect to be granted, additional approvals in other markets around the world. We look forward to finalizing our first commercial distribution agreement in Oman within the coming weeks and commencing commercial sales soon thereafter. We are laser-focused on opening new international markets and securing commercial distribution partners to rapidly and cost-effectively scale the business. Given the growing body of clinical data published in China supporting the benefits of our non-invasive, drug-free device, I am more confident than ever that our technology will play an important role in helping to combat the global mental health epidemic."
|
BDRX | Hot Stocks08:31 EST Biodexa Pharmaceuticals reports 12 month survival in MAGIC-G1 study of MTX110 - Biodexa Pharmaceuticals provided survival updates from its MAGIC-G1 study of MTX110 in patients with recurrent glioblastoma being conducted at Duke Cancer Institute and Baptist MD Anderson Cancer Center. In October 2023, Biodexa announced completion of recruitment of Cohort A of an ongoing open-label Phase I dose-escalation study designed to assess the feasibility and safety of intermittent infusions of MTX110 administered by convection enhanced delivery via implanted refillable pump and catheter. Because no drug-related adverse events were observed within the first 30 days from start of treatment, the minimum number of four patients were recruited into Cohort A. Patient #1 received weekly infusions of 60microM of MTX110 and survived for 12 months from the start of treatment. Patients #2, 3 and 4 each received weekly infusions of 90microM of MTX110, the expected optimum dose, and remain in the study.
|
ASTS | Hot Stocks08:24 EST AST SpaceMobile announces contract award from U.S. government 'prime contractor' - AST SpaceMobile announced a new contract award from a prime contractor working with the United States Government. "We are thrilled to announce this initiative with the United States Government," said Chris Ivory, Chief Commercial Officer and Head of Government Business of AST SpaceMobile. "We believe our patented technology, leveraging our large phased array antenna technology in space, creates opportunities for new mission-critical capabilities in the government sector. We are creating new robust and resilient communications solutions while also facilitating new use cases."
|
SATX | Hot Stocks08:21 EST Satixfy Communications announces NYSE acceptance of plan to regain compliance - SatixFy Communications announced that it received written notice from the NYSE American stating that it has reviewed the company's January 5 plan of compliance addressing how it intends to regain compliance with certain NYSE American continued listing standards and determined to accept the plan and grant a plan period for targeted completion of the Plan through May 30, 2025. The plan is based in part on expected upcoming business progress and technological development, including potential positive announcements it expects to report of new customers and new orders that it believes should evidence that its valuation should be higher. The NYSE American will review the company periodically for compliance with the initiatives outlined in the plan.
|
NFYEF | Hot Stocks08:19 EST NFI Group appoints Dewsnup as EVP, CFO - NFI Group announced that Brian Dewsnup has been appointed as Executive Vice President, EVP, and Chief Financial Officer, CFO, of the Company, effective March 1, 2024. Brian succeeds Pipasu Soni who has served as CFO since 2020 and is returning to the United States with his family to pursue other opportunities. Pipasu will support the transition and smooth handover to Brian through the second quarter of 2024. Dewsnup joined NFI through its 2013 acquisition of North American Bus Industries. At that time, Brian served as NABI's CFO and after its acquisition, as its Vice President and General Manager.
|
SAIC | Hot Stocks08:19 EST SAIC awarded $80.5M Navy task order - SAIC has been awarded a $80.5M task order by the U.S. Navy for the completion of the MK710 TSTS design and then to produce and deliver MK 710 Torpedo System Test Sets, or TSTS, to enhance the Navy's capability to provide the Submarine force with high quality, tested and validated MK 48 heavyweight torpedoes. Under the five-year contract, SAIC will provide MK 710 TSTS which will be used to test and validate the integrity and operational status of warshot MK 48 heavyweight torpedoes prior to delivery to the Navy. The testing and validation of exercise torpedoes supports the training, tactics development and certification of torpedo upgrades for Navy.
|
MCHP | Hot Stocks08:19 EST Microchip earns certification compliant to ISO/SAE 21434 - As everything from infotainment to engine systems in the automotive industry becomes more dependent on wireless and in-vehicle network connectivity, the need for robust cybersecurity measures has increased. The ISO/SAE 21434 standard has emerged to set requirements for road vehicle cybersecurity risk management processes. These cybersecurity requirements help regulate automotive products across the complete product lifecycle-from concept through design, production, maintenance and decommissioning. Adhering to these standards, Microchip Technology's corporate processes associated with specific automotive work products have recently been audited by a third party, UL Solutions, and certified as compliant to ISO/SAE 21434. Developed by the International Organization for Standardization in conjunction with the Society of Automobile Engineers International, the ISO/SAE 21434 standard was developed to help organizations define cybersecurity policies and manage risk. It is a demanding specification with 45 security categories, known as work products, each of which specifies a unique set of requirements that encompass all aspects of designing electrical and electronic systems for road vehicles, from ICs and software to firmware and libraries.
|
BLNK | Hot Stocks08:18 EST Blink Charging chosen by City of Frederick, Maryland for EV charging solutions - Blink Charging announced that the Company will be installing 20 IQ 200 chargers across four downtown parking garages in the City of Frederick, MD, for residents and visitors to utilize. The installation of 20 charging stations across the four designated parking garages - East All Saints, Carroll Creek, Court Street, and West Patrick - is a result of the City of Frederick's plan to cater to the charging needs of residents lacking home charging options and visitors to the city. "This expansion provides Blink Charging with the opportunity to expand our charging solutions into bustling cities, like Frederick," said Mike Battaglia, Chief Operating Officer of Blink Charging. "Our mission is to meet electric vehicle drivers, whether residents or visitors, with the convenience of charging on-the-go. We look forward to electrifying the City of Frederick and revolutionizing the future of transportation in the city."
|
G | Hot Stocks08:17 EST Genpact announces two executive appointments for focus on AI - Genpact announced two new executive leadership appointments. These appointments aim to propel the company into its next chapter of growth, leveraging data, technology, and AI-first principles. Vipin Gairola has been appointed Genpact's Global Operating Officer and is leading the charge of transforming service delivery for Genpact's clients by leveraging AI-led solutions. He is part of Genpact's Leadership Council and will lead the company's Operations and Cost Council. Gairola comes to Genpact from Accenture, where he served in several senior leadership roles over the past two decades. His most recent role was Chief Strategy Officer for Accenture Operations. Vidya Rao, Genpact's Chief Information Officer, takes on the expanded role of Chief Technology and Transformation Officer. In this role, she will be at the forefront of reimagining Genpact's internal processes, tools, technologies, and infrastructure with an AI-first approach.
|
SDIG | Hot Stocks08:17 EST Stronghold Digital Mining announces 192 Bitcoin mined in January - Stronghold Digital Mining provided the following updates regarding its operations and financial performance: Stronghold mined 192 Bitcoin in January 2024 and generated approximately $0.4 million in energy revenue, which represents the equivalent of approximately 10 additional Bitcoin based on the average price of Bitcoin during the month. This equates to approximately 202 of Bitcoin-equivalent production in January 2024, down approximately 6% from December 2023. The Company generated an estimated $8.0 million of revenue during January. The primary driver of the sequential decrease was a lower hash price of $0.08 per TH/s per day in January compared to $0.10 in December, which was due to lower transaction fees, averaging 12% in January compared to 26% in December, and 4% sequential growth in network hash rate.
|
PALI | Hot Stocks08:16 EST Palisade Bio announces formation of clinical advisory board - Palisade Bio announced the appointments of Bruce Sands, MD, MS and Florian Rieder, MD to its Clinical Advisory Board. Drs. Sands and Rieder will be advising Palisade on the advancement of its product candidates from preclinical studies to clinical trials.
|
GOOG GOOGL | Hot Stocks08:16 EST Google's Pichai sees Gemini as way for search to solve new use cases - CEO Sundar Pichai is speaking on CNBC.
|
NDAQ... | Hot Stocks08:16 EST Nasdaq Private Market closes $62.4M Series B Financing - Nasdaq Private Market closed its Series B financing. The $62.4 million round was led by Nasdaq with participation from current investors including Allen & Company, Citi, and Goldman Sachs. New investors in the Series B include BNP Paribas, DRW Venture Capital, UBS, and Wells Fargo. Since its spinout from Nasdaq in 2021, NPM has operated independently through an industry-backed consortium with a mission to deploy cutting-edge technology to accelerate the availability of secondary liquidity in private shares through its high-integrity trading, settlement, and data platform. NPM services some of the world's most innovative private companies with their liquidity needs for employees and institutional investors. The company has executed more than $50 billion in transactional value across 650 company-sponsored liquidity programs and block trades.
|
ACRV VIGL | Hot Stocks08:15 EST Acrivon Therapeutics appoints Magovcevic to board of directors - Acrivon Therapeutics (ACRV) announced the appointment of Ivana Magovcevic-Liebisch, Ph.D., J.D., to its board of directors. Dr. Magovcevic-Liebisch is the president and chief executive officer at Vigil Neuroscience (VIGL).
|
BWA | Hot Stocks08:14 EST BorgWarner begins eMotor rotor and stator production for Chinese EV company - BorgWarner has begun eMotor rotor and stator production for XPeng Motors, a Chinese Smart EV company. The product will be used on the X9 MPV as well as XPeng's next electric B-class sedan, with start of production planned for Q3 2024.
|
BWA | Hot Stocks08:13 EST BorgWarner signs contract extension for coolant heaters with global OEM - BorgWarner has extended its contract to supply 400V high voltage coolant heaters - HVCH - to a major global OEM. The technology will be used on the automaker's battery-electric light-vehicle platforms, specifically SUV and passenger truck programs. The business win is one of three contracts secured with North American OEMs for BorgWarner's HVCH. The HVCH was developed at BorgWarner's technical center in Auburn Hills, Michigan near the customer's technical center, allowing for seamless collaboration. The HVCH will be manufactured at BorgWarner's facility in Cadillac, Michigan.
|
GV | Hot Stocks08:12 EST Visionary Education changes name to 'Visionary Holdings' - Visionary Education Technology Holdings Group announced it has changed its legal name to "Visionary Holdings." The company's common shares will continue to trade under the ticker symbol "GV". No action by the company's shareholders is required with respect to the name change. The CUSIP number for the company's common shares will remain unchanged.
|
ASMB | Hot Stocks08:12 EST Assembly Biosciences to effect 1-for-12 reverse stock split on February 9 - Assembly Biosciences expects a 1-for-12 reverse stock split of its outstanding shares of common stock will be effective as of February 9, 2024. The company anticipates that its common stock will begin trading on a split-adjusted basis on The Nasdaq Global Select Market under the same symbol when the market opens on February 12, 2024, with the new CUSIP number 045396207. As of the effective time of the reverse stock split, every 12 issued and outstanding shares of the company's common stock will be automatically reclassified into one issued and outstanding share of the company's common stock. This will reduce the number of shares outstanding from approximately 65.8 million shares to approximately 5.5 million, subject to adjustment for fractional shares. The reverse stock split will not affect the number of authorized shares of common stock or the par value of the common stock.
|
BWA | Hot Stocks08:11 EST BorgWarner secures boosted dual inverter business with Chinese OEM - BorgWarner has secured a contract with a major Chinese OEM to supply its dual inverter with boost function on a series of the automaker's plug-in hybrid - PHEV - and range extended - REEV - electric vehicle passenger car platforms. The boost module is directly integrated into the 400V dual inverter to achieve a higher power density as well as meet local hybrid architecture standards within the Chinese market. The dual inverter with boost will be manufactured and assembled in BorgWarner's Suzhou, China plant, with production expected to begin September 2024.
|
GOOG GOOGL | Hot Stocks08:11 EST Google CEO Pichai says Gemini going to power 'a lot of products'
|
SRTS | Hot Stocks08:11 EST Sensus Healthcare issued U.S. patent for SRT-100 vision system - Sensus Healthcare announces that the U.S. Patent and Trademark Office, USPTO, has issued Patent No. 11,894,123 B2, titled "Radiotherapy Mobile and Wireless Device Workflow Management System." This new patent covers systems and methods for treating a patient with a radiotherapy system combining high-frequency ultrasound and optical imaging data. "The SRT-100 Vision is increasingly important to Sensus, and this new U.S. patent adds to our valuable intellectual property portfolio comprised of both domestic and international patents," said Michael Sardano, president and general counsel of Sensus Healthcare. "This USPTO issuance helps to ensure that our innovative products will remain protected for many years to come."
|
GOOG GOOGL | Hot Stocks08:11 EST Google CEO tells CNBC 2024 is start of 'Gemini era'
|
UAVS | Hot Stocks08:10 EST Ageagle Aerial Systems secures contract for eBee X, eBee TAC drones - AgEagle Aerial Systems announces the procurement of a fleet of eBee X and eBee TAC drones by UT-Battelle, LLC, which manages and operates the Oak Ridge National Laboratory, ORNL, on behalf of the U.S. Department of Energy, DOE. "We believe that the U.S. Department of Energy's choice to utilize our eBee X and eBee TAC systems underscores the value that our U.S. Government-certified drones bring to critical areas, such as research, security and emergency response. We are honored to be a trusted partner, and this recognition further motivates us to continue providing cutting-edge, certified security solutions that make a meaningful impact," stated Grant Begley, AgEagle's Interim CEO.
|
MDGL | Hot Stocks08:09 EST Madrigal Pharmaceuticals announces publication of Phase 3 MAESTRO-NASH trial - Madrigal Pharmaceuticals announced the publication of the pivotal Phase 3 MAESTRO-NASH trial of resmetirom in the New England Journal of Medicine. NASH is a leading cause of liver-related mortality and an increasing burden on healthcare systems globally. Resmetirom received Breakthrough Therapy designation from the FDA and is under review to become the first medicine approved to treat patients with NASH with liver fibrosis. The FDA granted resmetirom Priority Review and assigned a Prescription Drug User Fee Act date of March 14, 2024, the target date by which FDA intends to complete its review. The MAESTRO-NASH trial evaluates resmetirom treatment vs. placebo in patients with NASH with significant fibrosis, a population at elevated risk of progressing to cirrhosis and other adverse liver outcomes. The study includes a 52-week biopsy assessment to support accelerated approval and an ongoing 54-month outcomes study designed to generate confirmatory data that, if positive, will help verify resmetirom's clinical benefit and support full approval. Based on the results of the 52-week biopsy portion of the trial, MAESTRO-NASH is the only Phase 3 study in NASH to achieve both primary endpoints that FDA proposed as reasonably likely to predict clinical benefit: NASH resolution with no worsening of fibrosis and fibrosis reduction with no worsening of NAFLD activity score. Approximately 50% of patients treated with resmetirom 100 mg with biopsies at Week 52 showed either NASH resolution or fibrosis improvement. More than 80% of patients with biopsies at Week 52 had either fibrosis reversal or no progression of fibrosis. In addition to the two primary endpoints, multiple secondary endpoints were achieved in the MAESTRO-NASH study, including statistically significant reduction from baseline in liver enzymes. Reductions in atherogenic lipids and lipoproteins, fibrosis biomarkers and imaging tests were observed in resmetirom treatment arms as compared with placebo. MAESTRO-NASH also included many biomarker and imaging assessments that may be used in real world clinical practice to identify appropriate patients for treatment and monitor response to resmetirom, if approved. The incidence of serious adverse events was similar across the treatment groups, 10.9%, 12.7%, and 11.5% in 80 mg, 100 mg and placebo groups respectively. Transient diarrhea and nausea were more frequent with resmetirom at the beginning of therapy. No increase in the incidence of diarrhea and nausea was noted among resmetirom-treated patients relative to placebo-treated patients after the first few weeks of treatment. There was no incidence of drug-induced liver injury. There were no increases in bone fractures, or fracture risk score with resmetirom or increase in adverse events related to thyroid hormone effects outside the liver such as heart rate changes or sex hormone abnormalities.
|
INDP | Hot Stocks08:09 EST Indaptus Therapeutics launches new social media initiative to provide education - Indaptus Therapeutics announces the launch of a new social media initiative to provide education and updates about the company. Recognizing the importance of engaging with all stakeholders, Indaptus will generate content on a variety of digital platforms, including X and LinkedIn. Jeffrey Meckler, Indaptus Therapeutics' CEO, expressed enthusiasm about this initiative, stating, "Our goal is not only to advance groundbreaking treatments, but also to foster open communication and education around our work. Social media provides an ideal platform for connecting with a broader audience, sharing insights, and building a community that is passionate about medical advancements."
|
CRIS | Hot Stocks08:08 EST Curis sees cash, cash equivalents and investments sufficient into 2025 - As of December 31, 2023, Curis's cash, cash equivalents and investments totaled $56.3M, and the company had approximately 5.9 million shares of common stock outstanding. Curis expects its existing cash, cash equivalents and investments should enable its planned operations into 2025.
|
QNRX | Hot Stocks08:08 EST Quoin Pharmaceuticals files U.S., international patent application - Quoin Pharmaceuticals announced it has filed U.S. and International patent applications for a novel combination product as a potential treatment of Netherton Syndrome. This new product combines a broad spectrum serine protease inhibitor with an anti-inflammatory agent in a proprietary topical formulation. Quoin anticipates that patents arising from these applications will extend to at least 2044. "As we continue to advance the clinical development of Quoin's lead asset for Netherton Syndrome, we are pursuing opportunities to strengthen our industry-leading position in this disease space. Today's announcement further underscores our commitment to innovation and to the expansion of our intellectual property portfolio. This novel product concept, formulated as a topical lotion, addresses the combined roles that serine protease inhibition and inflammation play in this disease," said Dr. Michael Myers, Chief Executive Officer of Quoin.
|
CRIS | Hot Stocks08:08 EST Curis reports Q4 EPS ($2.03), consensus ($2.11) - Reports Q4 revenue $2.7M, consensus $3.02M. "The R/R PCNSL data presented at ASH highlight the potential of emavusertib in combination with ibrutinib to address a critical unmet need, for a patient population with no approved treatments, and achieve CR in patients who have failed prior BTKi therapy. The R/R AML FLT3 data highlight emavusertib's potential to provide targeted anti-cancer activity as a monotherapy. We have also begun working with clinical investigators to initiate a Phase 1 clinical study of emavusertib as an add-on agent to the combination of azacitidine and venetoclax in the front-line setting. Finally, the study evaluating emavusertib and pembrolizumab in metastatic melanoma will explore the potential of emavusertib and IRAK4 inhibition in solid tumors," said CEO James Dentzer. "We are encouraged by the reaction of the clinical community to the data released at ASH and are working to open additional clinical sites in the US and Europe for both the TakeAim Leukemia and Lymphoma studies."
|
AUID | Hot Stocks08:07 EST authID announces the appointment of new talent - authID announced the appointment of new talent that will position the Company for further growth in 2024 and beyond. Following the successful completion of its November 2023 fund-raise, the Company is expanding its sales, customer success, and engineering teams to drive quick execution on its sales and product pipeline and capitalize on the global demand for secure and seamless biometric authentication solutions. Prateek Bijapurkar, Director of Sales, has over 15 years of authentication and identity sales experience and most recently served as Enterprise Sales Manager at ForgeRock/Ping. Spencer Bybee, Director of Sales, holds over 25 years of strategic selling of security and identity solutions and arrives at authID having served in Executive Account Manager positions at Ping Identity and others. Linh Nguyen, Principal Solutions Architect, brings over 15 years of pre- and post-technical sales and product expertise. Most recently, he served as Principal Sales Engineer at ForgeRock/Ping where he tailored identity access solutions to meet customer needs and ensure post-implementation success.
|
GOOG GOOGL | Hot Stocks08:06 EST Google renaming AI chatbot to Gemini from Bard - Google is changing the name of its AI chatbot to Gemini from Bard to reflect its most advanced AI model of that name, the company said in a blog post. "Gemini is evolving to be more than just models," the company said. Gemini is available in 40 languages on the web, and is coming to a new Gemini app on Android and on the Google app on iOS, Google added. CEO Sundar Pichai said "For years, we've been investing deeply in AI as the single best way to improve Search and all of our products. We're excited by the progress, for example with our Search Generative Experience, or SGE, which you can try in Google Labs. AI is also now central to two businesses that have grown rapidly in recent years: our Cloud and Workspace services and our popular subscription service Google One, which is just about to cross 100 million subscribers... While today is about Gemini Advanced and its new capabilities, next week we'll share more details on what's coming for developers and Cloud customers." Reference Link
|
KRT | Hot Stocks08:06 EST Karat Packaging board raises quarterly cash dividend to 30c per share - Karat Packaging announced that its board of directors approved the payment of a regular quarterly dividend of 30c per share on the Company's common stock, reflecting an increase from the previous quarterly dividend of 20c per share. The dividend is payable on or about February 29, 2024, to the stockholders of record as of February 21, 2024.
|
OXLC | Hot Stocks08:05 EST Oxford Lane estimates NAV per share $4.92-$5.02 as of January 31 - Management's unaudited estimate of the range of the NAV per share of common stock as of January 31, 2024 is between $4.92 and $5.02. This estimate is not a comprehensive statement of our financial condition or results for the month ended January 31, 2024. This estimate did not undergo the Company's typical quarter-end financial closing procedures and was not approved by the Company's board of directors. We advise you that our NAV per share for the quarter ending March 31, 2024 may differ materially from this estimate, which is given only as of January 31, 2024. As of January 31, 2024, the Company had approximately 221.2 million shares of common stock issued and outstanding.
|
BYRN | Hot Stocks08:05 EST Byrna Technologies expanding manufacturing capabilities at Indiana facility - Byrna Technologies announced the expansion of its manufacturing capacity at its Fort Wayne, Indiana facility. This strategic move comes in response to the surge in demand stemming. The expansion initiative includes increasing production facility personnel by 25% and opening a second assembly line, paving the way for Byrna to boost its launcher output from 10,000 launchers per month to 12,500 units per month during a single shift. Mirroring the rise in demand in the DTC market, Byrna is also experiencing increased B2B demand.
|
ALIM | Hot Stocks08:05 EST Alimera announces NICE issued Final Draft Guidance on ILUVIEN - Alimera Sciences announces that the National Institute for Health and Care Excellence, NICE, has issued Final Draft Guidance recommending that patients with a natural lens being treated for chronic diabetic macular edema, DME, have access to ILUVIEN 190 microgram intravitreal implant in applicator. "This is great news that NICE has issued final draft guidance to make ILUVIEN available for phakic patients suffering with chronic DME," said Rick Eiswirth, President and Chief Executive Officer of Alimera. "These patients represent up to 75% of the overall DME population in the United Kingdom* who will now potentially have access to ILUVIEN to help control the recurrence of the disease for up to 36 months. We look forward to the publication of Final Guidance shortly."
|
SXTP TXMD | Hot Stocks08:04 EST 60 Degrees Pharmaceuticals appoints Kristen Landon as CCO - 60 Degrees Pharmaceuticals has appointed Kristen Landon to the newly created role of Chief Commercial Officer, effective immediately. Most recently, Ms Landon served as Senior Vice President of Marketing and Communications at TherapeuticsMD.
|
HUBC | Hot Stocks08:03 EST HUB Security announces achievement of its collaboration with Blackswan - HUB Cyber Security announces another significant achievement of its collaboration with Blackswan Technologies, a leading U.S. enterprise-AI vendor, to provide a joint solution under a landmark five-year agreement with one of Europe's top-tier banks. Noah Hershcoviz, CEO of HUB Cyber Security, stated, "This marks another significant milestone in our collaboration with Blackswan Technologies Ltd., representing a crucial advancement for HUB Cyber Security's penetration into the global financial markets. We are greatly encouraged by the trust shown by a prestigious bank in our capacity to provide essential solutions for its multinational infrastructure. This marks one more milestone of our journey to broaden our client base and extend our presence into new territories, further cementing HUB's position as a key player in the data-fabric domain."
|
VRSK | Hot Stocks08:02 EST Verisk Analytics launches generative AI tool in Discovery Navigator - Veris announced the launch of an automated generative artificial intelligence record summary capability in Discovery Navigator, one of the leading medical record review platforms for property and casualty claims professionals. The Discovery Navigator platform has already proven to be up to 90% faster than manual record review with up to 95% accuracy rates, allowing claims handlers to compile record summaries in a fraction of the time. The new generative AI auto-summary feature is designed to further simplify and accelerate the claims settlement process, allowing claims professionals to achieve efficient and accurate resolutions faster than ever before. Discovery Navigator's new auto-summary is built using Amazon Bedrock, a fully managed service from Amazon Web Services that makes foundation models from leading AI companies accessible via an API to build and scale generative AI applications. The auto-summary feature is designed to empower claims handlers of all skill levels to settle claims more efficiently. By automating the extraction and organization of key treatment data and medical information into a succinct summary, claims handlers can now identify and organize important bodily injury claims data faster than ever before, helping to facilitate more expedient settlements for their customers.
|
REPL | Hot Stocks08:02 EST Replimune Group announce cash runway extended - Cash runway extended to fund operations into 2H 2026
|
WDAY NSP | Hot Stocks08:00 EST Workday, Insperity to develop HR solution for small and midsize businesses - Workday (WDAY) and Insperity (NSP) announced an exclusive strategic partnership and plans to jointly develop, brand, market, and sell a preeminent full service HR solution for small and midsize businesses.
|
SABR | Hot Stocks07:56 EST Sabre announces board changes - Sabre announced changes to the composition of its Board of Directors. Elaine Paul has been elected to Sabre's Board of Directors, effective February 16. On that same date, Zane Rowe and Rachel Gonzalez will retire from the company's Board. The company also announced the planned retirement of two of its current directors, Zane Rowe and Rachel Gonzalez, effective February 16. With their departure and Paul's appointment, the company has reduced the size of its Board to eleven.
|
FRFHF | Hot Stocks07:51 EST Muddy Waters short Fairfax Financial - Muddy Waters' Carson Block is being interviewed on CNBC to discuss his short thesis on Fairfax Financial, which he claims is overstating book value.
|
NEXCF | Hot Stocks07:50 EST Nextech3D.AI expects to close several 3D modeling contracts in Q1 - 2024 Outlook & Highlights: Several significant enterprise 3D modeling contracted expected to close in Q1; MapD anticipates a jump of 51% or more in the average contract value due to increased pricing which has already been implemented and accepted by many customers. The Company is also projecting another 50% growth in new business leading to a projected 100%+ growth in 2024 revenue.
|
MAS | Hot Stocks07:49 EST Masco board boosts dividend 2% to 29c per share - Board declares a quarterly dividend of 29c per share, a 2% increase, payable on March 11 to shareholders of record on February 22...
|
LUCD | Hot Stocks07:47 EST Lucid Diagnostics to provide DNA test to WTC responder and survivor program - Lucid Diagnostics (LUCD) has contracted with the World Trade Center Health Program - WTCHP - to provide the EsoGuard Esophageal DNA test as a covered benefit to the more than 120,000 responders and survivors who participate in the program. The WTCHP provides medical monitoring and treatment to those directly affected by the 9/11 terrorist attacks, including members of the Fire Department of the City of New York and other emergency responders at the World Trade Center, recovery and cleanup workers and those who were in the New York City Disaster Area on September 11, 2001, or in the months that followed. EsoGuard is now reimbursable at $2,475.81 per test prescribed by clinicians at one of WTCHP's Clinical Centers of Excellence.
|
SKE | Hot Stocks07:47 EST Skeena Resources provides exploration update, 2024 outlook - Skeena Resources announced all drilling results from the 2023 exploration drilling program at the Eskay Creek Gold-Silver Project in the Golden Triangle of northwest British Columbia. Near Mine Exploratory Drilling: A total of 13 surface drillholes were completed in 2023 with the aim of following up on drill intersections discovered during the 2022 exploratory programs. Drilling in the vicinity surrounding the 22 Zone yielded new occurrences of footwall gold-silver mineralization highlighted by SK-23-1203, which intersected 19.87 g/t Au, 59.1 g/t Ag over 2.95 metres including 64.80 g/t Au, 132.0 g/t Ag over 0.85 metres and a second high grade interval averaging 21.10 g/t Au, 15.4 g/t Ag over 1.50 metres . Additional mineralization was identified 200 metres north of the 22 Zone by SK-23-1200 grading 0.63 g/t Au, 86.1 g/t Ag over 14.50 metres and 1.37 g/t Au, 7.6 g/t Ag over 5.00 metres . These new intersections are not expected to materially affect the existing open-pit Resources and Reserves in the 22 Zone. Regional Eskay Deeps Program: Discovery of new mineralization in 2022 at Eskay Deeps by exploratory drillhole SK-22-1081 prompted the 2023 Eskay Deeps Phase I exploration program. Completed in Q4 2023, the Phase I Deeps program was designed to test for additional high-grade Contact Mudstone mineralization in the down-dip extension of the Eskay Rift ~1,000 metres north of the current Eskay Creek Reserves. Targeting was supported by geological modelling and geophysical data, focusing on areas that were inadequately explored by previous operators. In total, 8 drillholes and 2 wedge branches were completed totalling 13,787 metres. To date, the Company has only tested an area of Contact Mudstone measuring 350 metres by 1,000 metres downdip of the main deposit with wide drill spacings in excess of 100 metres. Considerable exploration potential still exists in the Eskay Deeps as many prehistoric and modern day mineralized rift systems typically extend for tens of kilometres. All 2023 drillholes intersected anomalous trace mineralization in the Contact Mudstone. Additionally, 120 metres below the Contact Mudstone and hosted by footwall rhyolite breccias, 2023 drillhole SK-23-1182 intersected 3.92 g/t Au, 5.2 g/t Ag over 5.38 metres . SK-23-1182 is 50 metres from the discovery drillhole SK-22-1081, indicating that the mineralized hydrothermal system was still active in this area. Feeder zones similar to this typically have a high-grade expression at the Contact Mudstone, which is yet to be encountered in this area. By testing Eskay Deeps at widely spaced hole spacings, a wealth of new information was collected from the 2023 program which has yielded a refined interpretation of the Eskay Creek Rift Model at depth. The Rift Model will be further analyzed once combined with Skeena's proposed 2024 seismic survey. 2024 Seismic Survey: The Company is aiming to perform a surface based seismic survey in Summer 2024. It has been proven by previous operators that more conventional geophysical methods such as electromagnetics and induced polarization are unable to directly discern the Eskay Creek gold-silver mineralization. However, the Company is investigating the potential for a seismic survey to indirectly target mineralization by better defining the rift and Contact Mudstone at depth that is critical for hosting Eskay Creek style deposits. Additional Eskay Deeps drilling will be driven by the results of the seismic survey. 2024 Regional Exploration Plans: During H1 2024, Skeena will be finalizing a large airborne magnetics survey and data compilation for the new 74,633 hectare Hoodoo Project which was staked in October 2023. Remarkably, this ground was unclaimed mineral tenure with virtually no historical exploration despite possessing very high prospectivity for alkalic porphyry deposits. Alkalic gold-copper porphyry deposits in the cordillera of British Columbia typically rank as the higher-grade end members such as Galore Creek and New Afton. These specific deposits are attractive exploration targets based on their atypically high gold tenor. An accelerated exploration model will be employed in H2 2024 that judiciously ranks and ultimately culminates in drilling targets on the KSP and Hoodoo properties. The successes of the 2023 field program in discovering new gold-copper mineralization and increasing the geological understanding of the KSP and Hoodoo properties warrants augmented exploration in these areas. Overall, 14,000 metres has been budgeted for this regional program.
|
AVTBF | Hot Stocks07:45 EST Avant Brands executes four export agreements - Avant Brands provides an update on its export sales initiatives. Avant has executed four new cannabis export agreements in the past eight weeks. As a result, the Company now has a total of 11 active export agreements spanning three key markets. Furthermore, the Company has already commenced processing export permits and purchase orders for some of these new supply agreements. In addition to executing international cannabis supply agreements, the Company is pursuing international trademark licensing agreements focused on its BLK MKTTM brand. These agreements create an incremental revenue stream for the Company while building its flagship brand on the global stage. The first such agreement for the Israel market was signed in 2022. The Company is currently exploring expanding its licensing agreements into other markets and expects to provide additional updates in the future. Avant would also like to confirm that it is not one of the named companies in the anti-dumping investigation being conducted by Israel's Ministry of Economy. Avant's international business model is based on distributing premium quality flower at premium prices and conscientiously avoids selling product at low price points.
|
ICE | Hot Stocks07:44 EST IntercontinentalExchange increases quarterly dividend 7% to 45c per share - Intercontinental Exchange announced board authorization of its first quarter dividend of 45c per share, up 7% from its previous 42c per share quarterly dividend in 2023. The first quarter cash dividend is payable on March 29 to stockholders of record as of March 15. The ex-dividend date is March 14.
|
NEXCF | Hot Stocks07:44 EST Nextech3D.AI expects to close several 3D modeling contracts in Q3 - 2024 Outlook & Highlights: Several significant enterprise 3D modeling contracted expected to close in Q1; MapD anticipates a jump of 51% or more in the average contract value due to increased pricing which has already been implemented and accepted by many customers. The Company is also projecting another 50% growth in new business leading to a projected 100%+ growth in 2024 revenue.
|
QBTS | Hot Stocks07:42 EST D-Wave Quantum, Zapata Computing enter strategic partnership - D-Wave Quantum and Zapata Computing announced a multi-year strategic partnership to develop and bring to market commercial applications that combine the power of generative AI and quantum computing technologies. The partnership centers on joint technical development and commercial deployment of applications for customers faced with computationally complex problems. Using quantum-enabled machine learning algorithms, these applications will leverage the power of D-Wave's quantum technologies, which have been proven to perform coherent quantum annealing with 5,000+ qubits, pushing beyond the boundaries of what is possible with today's classical computers. The results of this collaboration will initially focus on building quantum generative AI models that accelerate the discovery of new molecules.
|
SNGX | Hot Stocks07:37 EST Soligenix forms Medical Advisory Board for Behcet's Disease - Soligenix announced the formation of a Medical Advisory Board - MAB - to provide medical/clinical strategic guidance to the company as it advances the clinical development of SGX945 for the treatment of Behcet's Disease. The FDA had granted Fast Track designation for dusquetide in the treatment of oral lesions of Behcet's Disease. Comprised of rheumatologists with experience in Behcet's Disease, the MAB will play an advisory role in the conduct of the upcoming Phase 2a clinical study, as well as in the design of subsequent clinical studies and associated regulatory interactions with health authorities. The MAB will provide feedback, input and guidance on clinical strategies and their implementation, as well as on other critical items, such as health economics and reimbursement, to assist Soligenix in meeting the needs of patients suffering from Behcet's Disease.
|
BCBNF | Hot Stocks07:36 EST Base Carbon provides corporate update, 2024 outlook - Base Carbon provides a corporate update and the Company's outlook for 2024. 2023 Highlights and 2024 Outlook: Targeted to receive approximately 6 million carbon credits from the Vietnam household devices project, for anticipated offtake proceeds of approximately US$29.1 million, and approximately 2.1 million carbon credits from the Rwanda cookstoves project in 2024. Receipt of approximately 1.1 million carbon credits and aggregate proceeds from the disposition of such credits of approximately $6.4 million, or C$0.072 per share, in 2023. Rwanda cookstoves project received Verra's first ever corresponding adjusted or "Article 6 Authorized Label" in December 2023. Execution of high quality nature-based carbon removal project agreement in August 2023, with approximately 4.7 of 6.5 million trees having been planted to date and project registration with Verra on track for end of 2024. Execution of a Letter of Intent for a partnership with STX during December 2023, to establish and launch an innovative fund for institutional investors to participate in offtake supported high quality carbon removal projects.
|
APCX | Hot Stocks07:33 EST AppTech Payments completes integration of Commerse product with FinZeo - AppTech Payments announces it has completed the integration of its Commerse product with its recent acquired FinZeo platform. Commerse is a patent-protected portal enabling Independent Sales Organizations and Independent Software Vendors to drive secure and scalable payments, digital banking, and merchant services from a single, unified stack. FinZeo focuses on the secure movement of money. "We believe our combined Fintech platform is positioned to enable traditional banks to more effectively compete in the Digital Banking sphere. AppTech now offers vertically integrated financial services to eliminate costs and redundancies while streamlining payments to enable real time transfer of funds without borders," said Luke D'Angelo, AppTech's Chairman & CEO. "This is a game-changer for the multi-billion dollar Specialty Payments space and certainly for AppTech. Our unified cloud-based platform frees the movement of money, safely and securely, and we stand ready to onboard our existing customers and any bank, merchant, or consumer."
|
SPGI | Hot Stocks07:33 EST S&P Global sees FY24 CapEx $165M-$175M - In addition to the above, the company expects 2024 cash provided by operating activities, less capital expenditures and distributions to noncontrolling interest holders, of approximately $4.1B. The company expects adjusted free cash flow, excluding certain items, of approximately $4.4B.
|
LILM | Hot Stocks07:32 EST Lilium designates future Orlando vertiport as key network hub - Lilium announced its designation of the future Orlando International Airport, MCO, vertiport as a network hub for Lilium Jet operators in central Florida. Lilium also announced its support for Florida House Bill 981, which proposes the designation of the Greater Orlando Aviation Authority, GOAA, as the Advanced Air Mobility, AAM, test site for the State of Florida. Lilium has been a driving force for AAM activity in Florida, announcing with the City of Orlando and Lake Nona the country's first urban and regional air mobility network in 2020. As the partners engaged in the work to bring the first full-scale eVTOL vertiport to fruition, all parties agreed that the best location would be a vertiport on airport property. "We are thrilled about the proposed advanced aviation center at Orlando International Airport and commend Orlando for its dedication and vision to advancing AAM," said Sebastien Borel, Chief Commercial Officer at Lilium. "Building a vertiport at the major-hub airport will ultimately enhance regional mobility by increasing passenger access and connectivity while allowing multiple operators to use the facility and share in the cost."
|
AMED | Hot Stocks07:32 EST Amedisys offers advanced molecular testing to care centers - Amedisys is now offering advanced molecular testing to its care centers nationwide. This innovative collaboration with Patient Choice Laboratories utilizes molecular testing for the swift and precise identification of pathogens in urine, respiratory and wound infections. By leveraging the latest in diagnostic technology, Amedisys aims to improve the quality of infection testing, ultimately facilitating better patient care and outcomes. Advanced molecular testing revolutionizes the diagnosis and management of infections, as it delivers rapid and precise results, ultimately enabling quicker initiation of appropriate treatment interventions. With improved accuracy, sensitivity and specificity, molecular testing significantly enhances the ability to identify infectious pathogens, supporting timely and targeted care strategies.
|
SGNLF | Hot Stocks07:23 EST Signal Gold announces diamond drill results from Goldboro Project - Signal Gold announced the final diamond drill results from the Company's growth exploration program at the Goldboro Project in Nova Scotia. The remaining diamond drill results are from 3,813 metres of drilling in 19 diamond drill holes that targeted near surface gold mineralization west of the Goldboro Mineral Resource and immediately to the east of the past producing Dolliver Mountain Gold Mine. The results included thirteen instances of visible gold and 74 separate intersections of gold mineralization, all located within the same anticline which hosts the Goldboro Deposit. These drill results are part of the larger growth exploration program in 2023 which comprised 11,435 metres in 61 diamond drill holes, focused on the discovery of gold mineralization to the west and along strike of the Goldboro Mineral Resource. "We are excited to announce these final drill results which, together with those previously released, conclusively demonstrate continuous gold mineralization along a strike length of 1.1 kilometres between the western extent of the Goldboro Deposit and the past producing Dolliver Mountain Mine, bringing the total strike length of known mineralization to 3.4 kilometres. This provides further confidence in the scalability of the Goldboro Deposit as well as in our exploration model and approach to gold discovery, which can be applied to 51 kilometres of strike extent along the combined Goldboro and Lower Seal Harbour trends. Our expanded and prospective land package of 27,200 hectares provides the opportunity to make additional discoveries in the Goldboro Gold District and to leverage the planned mine and mill infrastructure at Goldboro," said Kevin Bullock, President and CEO, Signal Gold Inc. Selected composited highlights from the current drill holes include: 76.31 g/t gold over 0.5 metres in hole BR-23-436; 12.88 g/t gold over 0.6 metres in hole BR-23-439; 7.73 g/t gold over 1.0 metres in hole BR-23-438; 2.10 g/t gold over 3.8 metres in hole BR-23-437, including 4.67 g/t gold over 1.0 metres; and 1.33 g/t gold over 3.0 metres in hole BR-23-433 including 2.75 g/t gold over 0.6 metres.
|
CLNE | Hot Stocks07:21 EST Clean Energy's RNG digester at Tri-Cross Dairy begins production - Clean Energy announced the successful completion and operational launch of its latest renewable natural gas - RNG - production facility at Tri-Cross Dairy in Viborg, South Dakota. The new RNG facility sits on a 5,000-cow dairy farm and is forecasted to produce 1 million gallons annually of negative carbon-intensity RNG. The construction costs of the RNG production facility, which includes the build of digesters and processing plant, totaled $34M and was completed in December 2023. The injecting of pipeline quality RNG began shortly after completion. Clean Energy is in process of filing the necessary applications to generate federal and state environmental credits. Financing for the Tri-Cross Dairy project is backed by one of Clean Energy's RNG production joint ventures and developed by Dynamic Renewables. The facility is one in a series of projects in the Midwest for which the companies have partnered together.
|
LVWR | Hot Stocks07:20 EST LiveWire sees FY24 electric motorcycle sales 1,000-1,500 units - Sees FY24 operating loss $115M-$125M.
|
HOLI | Hot Stocks07:18 EST Hollysys acquisition by Ascendent receives shareholder approval - Hollysys announced the voting results of the Extraordinary General Meeting of Ascendent Capital Partners, a private equity investment management firm managing assets for global institutional investors. The EGM concluded with the overwhelming majority of Hollysys shareholders approving all resolutions, including the resolution pursuant to which Ascendent will acquire all outstanding shares of Hollysys that it does not currently own for $26.50 per share in cash.
|
NEVDF | Hot Stocks07:18 EST Nevada Copper provides Pumpkin Hollow operations update - Nevada Copper provides updates on restart activities at its Pumpkin Hollow underground mine. Randy Buffington, President and CEO of Nevada Copper, stated, "Since restarting mining and milling operations, we've made progress in a number of areas, including completion of life of mine projects such as the Geho dewatering system and phase two of the underground crushing and ore handling system, development of significant stope inventory underground and realignment of the site operations team, under the leadership of Chuck Pollard as Assistant General Manager. However, several unforeseen setbacks impacted our progress on meeting operational targets. We took critical steps and refocused resources to mitigate and address these issues. The hoisting and ore handling system has returned to full capacity and mill operations continue to incrementally improve with over two months of mill feed stockpiled on surface. While I am disappointed that these challenges have negatively impacted our ability to meet hoisting and processing targets, we continue to ramp-up toward steady state operations." Recent Operating Developments: Hoisting improvements implemented, hoisting increased in the fourth quarter; Over 135,000 tons of ore stockpiled on surface; over 190,000 tons of stope ore ready to mine; Unexpected bottlenecks encountered in process plant systems are being mitigated; Third ore pass and temporary use of ore bin from new life-of-mine ore handling system provides material handling capacity to meet plan until underground crusher is installed; Paste plant fully commissioned; LOM fuel, paste lines in progress; LOM dewatering system in place; Development contractor ramping up development and expected to meet targets. As noted above, several key milestones have been achieved across many aspects of the mine, including completion of critical LOM projects and restart of all significant operations, however, key fourth quarter operational targets were not met. T Considering the unexpected challenges, the Company has generated lower sales through the ramp-up process than previously anticipated, negatively impacting financing requirements. As previously disclosed, the Company has fully drawn US$25 million of debt pursuant to a deferred funding agreement with its two largest shareholders, Pala Investments and Mercuria Holdings. Pala has since been providing sole funding for the Company's operating needs in the form of debt on similar terms to the Company's October 2022 credit facility with Pala, except such debt is unsecured and not guaranteed by the Company's subsidiaries and the interest rate on the debt is SOFR + 10% and it matures in December 2024. The Company requires additional financing in order to complete the ramp-up of the Underground Mine. While Pala has continued to support the Company, it is under no obligation to do so. The Company is also in discussions with other third parties. There is no assurance that additional financing will be obtained in a sufficient amount, or at all. In the absence of securing sufficient funding from Pala or other third parties, the Company will not be able to continue carrying on business.
|
IPG | Hot Stocks07:17 EST Interpublic Group board increases quarterly dividend 6% to 33c per share - Interpublic Group announced that the company's Board of Directors has declared a quarterly dividend on IPG common stock of $0.33 per share, payable on March 15, 2024, to holders of record at the close of business on March 1, 2024. The increase in the dividend from $0.31 to $0.33 per share represents a six percent increase to the Company's quarterly dividend.
|
NKOSF | Hot Stocks07:16 EST Labrador Gold announces new discovery at Fire Ant Zone, Hopedale project - Labrador Gold announces the results of the 2023 exploration program at its 100% owned Hopedale Project in Labrador. The district scale Hopedale property covers a 43km strike length of the Florence Lake greenstone belt which has characteristics typical of greenstone belts around the world but has been underexplored by comparison. "Our 2023 exploration program over the district scale Hopedale property confirmed the significant prospectivity of the Rusty Ridge area for nickel associated with ultramafic rocks and identified a new area, Last Resort, with similar potential for magmatic sulphide type mineralization," said Roger Moss, President and CEO of Labrador Gold. "The highest grade gold found on the property to date, 106g/t Au and 20.4g/t Ag, was sampled at a new occurrence, Fire Ant, in the Rusty Ridge area and brings the number of significant gold occurrences on the property to five."
|
ACB | Hot Stocks07:15 EST Aurora acquires remaining 90% equity interest of Indica Industries for A$50M - Aurora Cannabis announced that a wholly-owned subsidiary of the company has acquired the remaining approximately 90% equity interest of Indica Industries, or MedReleaf Australia, that Aurora did not previously own, at an enterprise value of A$50M, subject to customary adjustments. Aurora paid A$9.45M in cash with the balance of the purchase price satisfied by the issuance of common shares of Aurora. As consideration, Aurora issued the selling shareholders an aggregate of approximately 69.5M Aurora Shares and paid the selling shareholders A$9.45M in cash, subject to customary adjustments post-closing. Approximately 10% of the consideration will be held in escrow to ensure certain obligations of the selling shareholders.
|
TLRY | Hot Stocks07:14 EST Tilray, Atlanta Track Club join forces to promote active lifestyles - SweetWater Brewing, a subsidiary of Tilray Brands, announced a new partnership with Atlanta Track Club, the second-largest running organization in the United States that delivers world-class running events and training programs along with community outreach in the Metro Atlanta Area. Through this collaborative partnership, SweetWater will enhance race-day experiences by engaging in activations and working closely with Atlanta Track Club to host community-building events. SweetWater will also serve its refreshing selection of craft beers at Atlanta Track Club events as part of the Peachtree Road Race festivities. "We are excited to partner with Atlanta Track Club and support their incredible work," said Ty Gilmore, President of U.S. Beers for Tilray Brands. "As a brand deeply rooted in our community, we believe it's important to support organizations that inspire individuals to live balanced and active lives and foster a strong sense of community through shared experiences."
|
CMLS | Hot Stocks07:14 EST Cumulus Media's Westwood One to present Super Bowl LVIII coverage - Cumulus Media's Westwood One will present comprehensive live coverage and play-by-play of Super Bowl LVIII on Sunday, February 11, 2024, when the AFC champion Kansas City Chiefs meet the NFC champion San Francisco 49ers at Allegiant Stadium in Las Vegas, Nevada. Super Bowl LVIII will be the 51st time Westwood One will broadcast America's biggest sporting event.Kevin Harlan will handle play-by-play duties for the Super Bowl for the 14th straight year, with Super Bowl XXXIV MVP and Hall of Fame quarterback Kurt Warner returning for the sixth consecutive year as lead analyst. Dean Blandino will also join the radio broadcast booth as rules analyst for this year's Super Bowl. For the fifth time, Laura Okmin will patrol the sidelines, along with former defensive lineman Mike Golic, who returns for his third Super Bowl with Westwood One's broadcast crew. Scott Graham and three-time Super Bowl champion Devin McCourty will host Westwood One's pregame, halftime, and postgame coverage live from Allegiant Stadium, with Devin's twin brother and fellow Super Bowl champion Jason McCourty and former NFL offensive lineman Ross Tucker also contributing to the pregame coverage.
|
GOLD | Hot Stocks07:13 EST Barrick Gold announces third year of reserve growth at sustained quality - Barrick Gold grew attributable proven and probable gold mineral reserves by 5.0 million ounces before 2023 depletion, while continuing to maintain the quality of the mineral reserve base. Attributable proven and probable mineral reserves now stand at 77 million ounces at 1.65g/t, increasing from 76 million ounces at 1.67g/t in 2022. Led by the Africa & Middle East region, Barrick has delivered a third consecutive year of organic gold reserve growth over and above annual depletion. This unremitting focus on asset quality has successfully delivered replacement of over 140% of the company's gold reserve depletion since end of year 2019, adding almost 29 million ounces4 of attributable proven and probable reserves or 44 million ounces4 of proven and probable reserves on a 100% basis. President and chief executive Mark Bristow said Barrick's strategy of investing in organic growth through exploration and mineral resource management has set us apart within the industry, creating real value through discovery and development, rather than relying upon increases in commodity prices to provide value to high premium mergers and acquisitions. "In order for our industry to help build a better world, we have to invest in our own future by creating value through exploration, leveraging our capital infrastructure base by replacing the ounces that we mine, which in turn enables us to provide multi-generational investment in our communities, developing local service provider partnerships, and investing in improving our operating environments" said Bristow.
|
MIXT | Hot Stocks07:12 EST MiX Telematics selected by Transport for Greater Manchester - MiX Telematics announced that Transport for Greater Manchester - TFGM - has appointed MiX to enhance fleet safety, efficiency and sustainability. Transport for Greater Manchester is a local government body responsible for co-ordinating transport services throughout Greater Manchester in North West England. The partnership will equip the full bus fleet of nearly 2,000 vehicles with MiX Telematics' SaaS solution, in-cab driver feedback and integration.
|
ALEC GSK | Hot Stocks07:12 EST Alector announces first patient dosed in PROGRESS-AD Phase 2 trial - Alector (ALEC) and GSK plc (GSK) announced that the first patient has been dosed in PROGRESS-AD, the global Phase 2 clinical trial of AL101/GSK4527226 in patients with early Alzheimer's disease, including mild cognitive impairment and mild dementia due to AD. Alector and GSK are co-developing and will be co-commercializing AL101 for the potential treatment of more prevalent neurodegenerative diseases, including AD and Parkinson's disease. "In partnership with GSK, we are delighted to announce the dosing of the first patient in PROGRESS-AD, the Phase 2 trial of AL101 for the treatment of early Alzheimer's disease, which remains a high unmet need," said Arnon Rosenthal, Ph.D., Chief Executive Officer of Alector. "Modest reduction in the levels of progranulin due to genetic mutations has been shown to be associated with an increased risk of developing Alzheimer's disease. Conversely, an elevation of progranulin was shown to be protective in animal models of Alzheimer's disease. This provides a genetic and biological rationale for considering the investigational testing of AL101 in Alzheimer's disease. To date, AL101 has been shown to be generally well tolerated and elevated progranulin levels in healthy volunteers. We look forward to continuing the development of AL101 in this Phase 2 trial with our partner GSK who is operationalizing the trial. AL101 is an exciting addition to our expanding portfolio of investigational dementia therapies, which includes the TREM2-activating antibody AL002, currently in the final stages of a Phase 2 trial in Alzheimer's disease, and latozinemab, a progranulin-elevating antibody, advancing through the final stages of a pivotal Phase 3 trial in frontotemporal dementia due to a progranulin gene mutation."
|
FHTX LLY | Hot Stocks07:11 EST Foghorn Therapeutics says Lilly selects FHD-909 for clinical development - Foghorn Therapeutics (FHTX) announced that Lilly (LLY) has selected FHD-909, a first-in-class oral BRM selective inhibitor, for clinical development. Lilly plans to file an IND for FHD-909 in Q2 2024. The primary target patient population is BRG1 mutated non-small cell lung cancer. Selective BRM inhibition has been a sought-after objective in cancer research for many years. A variety of tumor types, including NSCLC, are known to have mutations in BRG1, which we believe make them dependent on BRM activity for their survival. Selective blocking of BRM activity is considered a promising strategy for causing tumor cell death while sparing healthy cells. In December 2021, Foghorn announced a strategic collaboration with Lilly to create novel oncology medicines. The collaboration includes a US 50/50 co-development and co-commercialization agreement for Foghorn's Selective BRM oncology program and an additional undisclosed oncology target. In addition, the collaboration includes three discovery programs using Foghorn's proprietary Gene Traffic Control platform. The Companies plan to present preclinical data at upcoming scientific conferences.
|
BCDA | Hot Stocks07:11 EST BioCardia announces activation of CardiAMP heart failure II phase 3 study - BioCardia is targeting heart failure and chronic myocardial ischemia as potential indications for its biotherapeutic candidates: autologous CardiAMP cell therapy and allogeneic CardiALLO cell therapy. The Company announces activation of CardiAMP HF II, a randomized controlled pivotal trial of its CardiAMP autologous cell therapy for patients with ischemic heart failure. The study was approved by FDA in Q4 2023 for the treatment of ischemic etiology heart failure of reduced ejection fraction. The data supporting the design of CardiAMP HF II is from the interim results of the ongoing CardiAMP Heart Failure autologous cell therapy study, a randomized, double blind, controlled study that enrolled 125 patients with New York Heart Association Class II and III ischemic heart failure. The interim results of the study will be shared at the upcoming Technology and Heart Failure Therapeutics meeting on March 4, 2024, with final results expected in Q4 2024. The primary endpoint for CardiAMP HF II is a Finkelstein-Schoenfeld composite difference between groups based on all-cause heart death, major adverse cardiac and cerebrovascular events, and quality of life as measured by Minnesota Living with Heart Failure Questionnaire at a minimum of one year and a maximum of two-year follow-up.
|
IONS AZN | Hot Stocks07:10 EST Ionis Pharmaceuticals: FDA grants Fast Track designation to eplontersen - Ionis Pharmaceuticals (IONS) announced that the U.S. FDA has granted Fast Track designation to Ionis and AstraZeneca's (AZN) eplontersen, an investigational therapy for the treatment of transthyretin-mediated amyloid cardiomyopathy in adults.
|
GILT | Hot Stocks07:09 EST Gilat Satellite awarded $10M follow-on order from U.S. Department of Defense - Gilat Satellite Networks announced that the US Department of Defense awarded a $10 million follow-on order to one of the company's US-based subsidiaries, DataPath. This additional order is for DKET 3421 terminals, transportable satcom hubs that deliver the operational flexibility, capacity, connectivity, and control required to ensure success anywhere in the world. "Our solutions are specifically tailored to meet the strict requirements of government and military operations. We take great pride in our unwavering dedication to meeting and exceeding the expectations of our customers, and our team works tirelessly to provide innovative solutions to their mission-critical requirements," said Barry W. Botts, Vice President, Sales and Business Development for DataPath. "This follow-on order is a testament to the outstanding performance and satisfaction our solutions consistently deliver."
|
PLUG | Hot Stocks07:08 EST Plug Power cryogenic trailers leave Tennessee plant for customer deliveries - Plug Power announces that Plug cryogenic trailers filled with liquid hydrogen are being deployed from its recently commissioned Tennessee hydrogen production plant for customer deliveries. The achievement comes two days following the official commencement of operations at the Charleston, TN production plant and is already servicing east coast pedestal customers, including Walmart, Home Depot and others. "Plug is deploying hydrogen production plants at a pace and scale unmatched by others in our sector," said Andy Marsh, CEO of Plug Power. "Unlike anyone else in the industry, Plug's energy business spans cryogenic equipment, liquefaction, hydrogen and electrolyzers. Proving the viability of these solutions, a goal previously only within the reach of traditional industrial gas companies, signals a new era for the hydrogen industry, led by Plug."
|
HSY | Hot Stocks07:07 EST Hershey raises quarterly dividend 15% to $1.37 per share - The Board of Directors of The Hershey Company announced quarterly dividends of $1.37 on the Common Stock and $1.245 on the Class B Common Stock, an increase of 15% or 17.8c and 16.2c per share, respectively. The dividends were declared February 7, and are payable March 15 to stockholders of record as of February 20. It is the 376th consecutive regular dividend on the Common Stock and the 157th consecutive regular dividend on the Class B Common Stock.
|
AKTS | Hot Stocks07:07 EST Akoustis achieves Wi-Fi 7 design win, volume orders for two new programs - Akoustis Technologies announced that multiple narrowband and wideband patented XBAW filters are being designed into two new programs with an enterprise Wi-Fi access point solutions provider. Multiple narrowband and wideband XBAW filters will be employed in a company's new suite of leading 4x4 and 2x2 multi-user, multiple-in-multiple-out Wi-Fi 7 AP routers. The utilized filters span the frequency ranges of 5 to 7 GHz meeting the stringent coexist requirements covering full U-NII 1 to 4 and U-NII 5 to 8. Akoustis has received volume orders from the customer for supporting the development and leading to production ramp in the second half of the calendar year 2024. Jeff Shealy, founder and CEO of Akoustis, stated, "We are excited to incorporate our patented XBAW(R) RF filters into a new line of cutting-edge routers with a current Tier-1 enterprise Wi-Fi provider." Mr. Shealy continued, "The Company provides a complete set of narrowband and wideband XBAW(R) filters to enable disruptive performance in new Wi-Fi 7 enterprise solutions."
|
KRYS | Hot Stocks07:06 EST Krystal Biotech announces publication in NEJM on application of B-VEC - Krystal Biotech announced data on the compassionate use of beremagene geperpavec, B-VEC, administered as an eyedrop to treat a patient with dystrophic epidermolysis bullosa with cicatrizing conjunctivitis has been published in the New England Journal of Medicine, NEJM. The full manuscript, titled "Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa," can be found in the February 8, 2024 issue of the NEJM. A patient presented with severe cicatrizing conjunctivitis secondary to DEB. Surgical symblepharon lysis of the patient's right eye with pannus removal was conducted and regular administration of B-VEC as an eyedrop directly to the eye were added to routine post-surgical care, three times weekly for the first two weeks and then once weekly. B-VEC application frequency was further decreased to once monthly once the corneal epithelium was healed. B-VEC was well tolerated and associated with full corneal healing by 3 months as well as significant visual acuity improvement from hand motion to 20/25 at 8 months.
|
ACB | Hot Stocks07:06 EST Aurora Cannabis provides Q4 guidance - In fiscal Q4 2024, the company expects revenue from Canadian medical and consumer segments to be steady quarter over quarter, while Europe and Australia should provide modest growth in their regions. For plant propagation, we expect to see seasonally higher revenues and gross profit that should be in-line with historical performance in the comparable prior year period. Revenue increases combined with ongoing cost control are expected to result in continued positive Adjusted EBITDA in Q4 2024. Aurora's achievement of significant and sustainable operating cost and SG&A reductions has now resulted in five consecutive quarters with positive adjusted EBITDA. Continuing growth in positive adjusted EBITDA paves the path towards positive free cashflow in calendar year 2024.
|
ADVM | Hot Stocks07:05 EST Adverum Biotechnologies announces efficacy, safety data from LUNA Phase 2 trial - Adverum Biotechnologies announced preliminary safety and efficacy data from the ongoing LUNA Phase 2 trial in patients with wet age-related macular degeneration, AMD. These data are being presented by Dr. Arshad Khanani today at the 47th Annual Meeting of the Macula Society. LUNA Preliminary Efficacy and Safety Data Summary: Both the 2E11 and 6E10 doses demonstrated maintenance of visual and anatomic outcomes. Notably, both doses resulted in a potentially best-in-class reduction in annualized anti-vascular endothelial growth factor injections and the percentage of patients remaining free of annualized injections, with data trending similar to or better than the OPTIC study. Treatment Burden Reduction: At 26 weeks, Ixo-vec demonstrated annualized reduction in anti-VEGF injection rates of 90% at 6E10 and 94% at 2E11. At 26 weeks, Ixo-vec demonstrated injection free rates of 68% at 6E10 and 85% at 2E11. Visual and Anatomic Outcomes: Visual acuity was maintained at both dose levels. Anatomic endpoints were maintained at both dose levels. In a sub-group analysis of patients with higher baseline CST, a greater reduction in CST was demonstrated, indicating the robust efficacy potential of Ixo-vec gene therapy. Safety: Preliminary data suggest corticosteroid prophylaxis optimization at both the 2E11 and 6E10 doses appears to result in improved inflammatory profiles in LUNA as compared to OPTIC study results. Ixo-vec was generally well-tolerated, and when present intraocular inflammation was responsive to local corticosteroids. No Ixo-vec related serious adverse events were reported. No episcleritis, vasculitis, retinitis, choroiditis, vascular occlusion or hypotony were reported. Preliminary data indicate that select prophylactic regimens are outperforming others that do not provide sustained prophylaxis.
|
HOG | Hot Stocks07:02 EST Harley-Davidson sees FY24 HDMC revenue flat to down 9% - For the full year 2024, the company expects: HDMC: revenue flat to down 9% and operating income margin of 12.6% to 13.6%. HDFS: operating income flat to up 5%. LiveWire: electric motorcycle unit sales of 1,000 to 1,500 and operating loss of $115 to $125 million. Harley-Davidson, Inc: capital investments of $225 to $250 million.
|
VIAO | Hot Stocks06:57 EST VIA Optronics signs design and development contract with Immervision - VIA optronics announced the signing of a contract for the design and development of a new automotive camera with Immervision, a specialist in the design of advanced vision systems. VIA will work with Immervision to develop a specialized lens technology to customize and produce exterior automotive cameras which can be brought to market quickly while reducing non-recurring engineering costs. The new technology for the next generation cameras will enhance VIA's camera portfolio and meet growing customer demand for a variety of field of views. The company expects these next generation cameras to be used most frequently with e-mirror and surround view applications.
|
TPX | Hot Stocks06:55 EST Tempur Sealy comments on pending Mattress Firm transaction - Company chairman and CEO Scott Thompson commented, "Regarding the pending Mattress Firm transaction, we certified compliance with the Federal Trade Commission's second request in the fourth quarter of 2023 and expect the transaction to close in the second half of 2024. Both Tempur Sealy and Mattress Firm continue to make joint progress in integration planning, including the signing of post-closing supply agreements with numerous companies providing Mattress Firm product. These agreements provide access post-closing to certain consumer-desired products, solidifying important supplier relationships. Additional discussions regarding post-closing supplier relationships are ongoing. Overall, we are optimistic about Tempur Sealy's future and look forward to welcoming Mattress Firm into the organization later this year."
|
TPX | Hot Stocks06:54 EST Tempur Sealy increases quarterly dividend 18% to 13c per share - The company announced that its board of directors increased the quarterly cash dividend by 18% to 13c per share. This is the fourth increase to the dividend in the last few years. The dividend is payable on March 7 to shareholders of record at the close of business on February 22.
|
BKE | Hot Stocks06:52 EST The Buckle reports January SSS down 17.4% - The Buckle announced that comparable store net sales, for stores open at least one year, for the 5-week period ended February 3, 2024 decreased 17.4 percent from comparable store net sales for the 5-week period ended February 4, 2023. Net sales for the 5-week fiscal month ended February 3, 2024 increased 4.5 percent to $72.6 million from net sales of $69.4 million for the prior year 4-week fiscal month ended January 28, 2023. Comparable store net sales for the 14-week fourth quarter ended February 3, 2024 decreased 9.6 percent from comparable store net sales for the 14-week period ended February 4, 2023. Net sales for the 14-week fiscal fourth quarter ended February 3, 2024 decreased 4.8 percent to $382.4 million compared to net sales of $401.8 million for the prior year 13-week fiscal fourth quarter ended January 28, 2023.
|
TRI | Hot Stocks06:49 EST Thomson Reuters announces 2025-2026 targets - The company said, "For the 2025-2026 period, the company targets an organic revenue growth range of 6.5%-8%, driven by 8%-9% for the "Big 3" segments. The company targets adjusted EBITDA margin expansion of approximately 75 basis points in 2025, followed by at least 50 basis points in 2026. It anticipates accrued capital expenditures as a percentage of revenues to be approximately 8%, and 2026 free cash flow to range from $2.0-$2.1 billion. This financial framework assumes constant currency rates and incorporates the recent Pagero and World Business Media acquisitions but excludes the impact of any future acquisitions or dispositions that may occur during this time horizon."
|
WMS | Hot Stocks06:44 EST Advanced Drainage declares quarterly dividend of 14c per share - A 17% increase over the prior year dividend amount. The quarterly cash dividend of 14c per share will be paid on March 15 to shareholders of record at the close of business on March 1.
|
BWA BYDDF | Hot Stocks06:39 EST BorgWarner enters relationship pact with BYD subsidiary for LFP battery packs - BorgWarner (BWA) announced a strategic relationship agreement with FinDreams Battery, a subsidiary of BYD (BYDDF). Under this agreement, BorgWarner will be the only non-OEM localized manufacturer, unaffiliated with FinDreams Battery, with rights to localize LFP battery packs for commercial vehicles utilizing FinDreams Battery blade cells in Europe, the Americas, and select regions of Asia Pacific. The duration of the agreement is eight years. In addition to receiving blade cells for manufacturing LFP battery packs in the covered geographies, BorgWarner will receive a license from FinDreams Battery to use FinDreams Battery's intellectual property related to its battery pack design and manufacturing process.
|
ITT | Hot Stocks06:34 EST ITT raises quarterly dividend 10% to 31.9c per share - Board of Directors approved the cash dividend for the first quarter of 2024, which will be payable on April 1 to shareholders of record as of the close of business on March 8.
|
SNA | Hot Stocks06:31 EST Snap-On sees 2024 CapEx $100M-$110M - "We believe that our markets and our operations possess and have demonstrated continuing and considerable resilience against the uncertainties of the current environment. In 2024, Snap-on expects to make ongoing progress along its defined runways for coherent growth, leveraging capabilities already demonstrated in the automotive repair arena and developing and expanding its professional customer base, not only in automotive repair, but in adjacent markets, additional geographies and other areas, including extending in critical industries, where the cost and penalties for failure can be high. In pursuit of these initiatives, it is projected that capital expenditures in 2024 will be in a range of $100 million to $110 million. Snap-on currently anticipates that its full-year 2024 effective income tax rate will be in the range of 22% to 23%."
|
PSN | Hot Stocks06:26 EST Parsons awarded $48M task order on U.S. Army's RS3 contract - Parsons announced that the company was awarded a $48M task order on the U.S. Army's Responsive Strategic Sourcing for Services contract to support the software development lifecycle for command and control applications. The new contract will have a one-year base period with two one-year option periods and expands the company's support to the U.S. Army's RS3 mission.
|
IREN | Hot Stocks06:08 EST Iris Energy signs GPU cloud service contract with AI company - Iris Energy commenced GPU cloud service with AI company Poolside AI SAS. The contract is for an initial 3-month term and extension option for an additional 3 months at the customer's election. Poolside closed a $126M seed funding round in mid-2023 and is building AI for software development. The cloud service commenced on February 5, 2024.
|
DIS TSLA | Hot Stocks06:04 EST Musk says willing to give legal support to people who want to sue Disney - Tesla (TSLA) CEO Elon Musk is soliciting people who want to sue Disney (DIS) for discrimination and says he is willing to help pay for their cases, Musk said in a post on X, which he owns. Reference Link
|
HOLI | Hot Stocks05:58 EST Hollysys announces shareholder approval of Ascendent merger agreement - Hollysys announced that, at an extraordinary general meeting of shareholders, the company's shareholders voted in favor of, among other things, the proposal to authorize and approve the agreement and plan of merger, dated as of December 11, 2023, by and among the company and entities affiliated with Ascendent Capital Partners, Superior Technologies Holding and Superior Technologies Mergersub, pursuant to which, Merger Sub will merge with and into the company, with the company continuing as the surviving company and becoming a wholly owned subsidiary of Parent, the articles of merger and the plan of merger to be filed with the Registrar of Corporate Affairs of the British Virgin Islands, and the transactions contemplated thereby, including the merger.
|
SAVE JBLU | Hot Stocks05:55 EST Spirit Airlines provides update on JetBlue merger agreement - The company said, "On October 19, 2022, Spirit (SAVE) stockholders voted to approve the Agreement and Plan of Merger (the "Merger Agreement"), among Spirit, JetBlue Airways Corporation (JBLU) and Sundown Acquisition Corp., a direct, wholly owned subsidiary of JetBlue, which was entered into on July 28, 2022. The completion of the transaction is subject to customary closing conditions, including receipt of required regulatory approvals. Spirit and JetBlue expect to conclude the regulatory process and close the transaction no later than the first half of 2024. On March 7, 2023, the U.S. Justice Department filed suit to block the merger. The trial for the lawsuit began on October 31, 2023 in the U.S. District Court for the District of Massachusetts (the "Court") and concluded on December 5, 2023. On January 16, 2024, the Court granted a injunction against the Merger (the "Injunction"). On January 19, 2024, Spirit and JetBlue filed a notice of appeal and to reverse the Injunction and allow Spirit and JetBlue to complete the Merger. On February 2, 2024, the Court of Appeals granted our motion, stating it would hear arguments in June 2024."
|
BNTX AUTL | Hot Stocks05:49 EST BioNTech, Autolus Therapeutics announce strategic alliance - BioNTech (BNTX) and Autolus Therapeutics (AUTL) announced a strategic collaboration aimed at advancing both companies' autologous CAR-T programs towards commercialization, pending regulatory authorizations. In connection with the strategic collaboration, the companies entered into a license and option agreement and a securities purchase agreement. BioNTech has agreed to purchase $200M of Autolus' American Depositary Shares in a private placement. BioNTech will have a right to appoint a director to the board of Autolus. Under the terms of the license and option agreement, BioNTech will make a cash payment of $50M and is granted the following rights in exchange: BioNTech is eligible to receive an up to mid-single digit royalty on obe-cel net sales. Autolus will retain full rights to and control of the development and commercialization of obe-cel. BioNTech has the option to access Autolus' commercial and clinical site network, manufacturing capacities in the United Kingdom and commercial supply infrastructure in a cost-efficient set-up in order to accelerate the development of BNT211 in additional CLDN6+ tumor types. BioNTech plans to have 10 or more ongoing potentially registrational clinical trials in the pipeline by the end of 2024, including its fully owned CLDN6 CAR-T program BNT211 in relapsed or refractory germ cell tumors. Autolus will lead the development and commercialization for AUTO1/22 and AUTO6NG in any oncology indication with BioNTech having an option to support certain development activities and co-commercialize both candidates in certain territories. If BioNTech exercises an option, it will receive a profit share with respect to such exercised product candidate worldwide while Autolus will be eligible to receive an option exercise fee, milestone payments and co-funding of development expenses. Autolus granted BioNTech an exclusive license to develop and commercialize therapeutics incorporating certain of Autolus' proprietary binders along with options to license binders and cell programming technology for use in BioNTech's in vivo cell therapy development programs and investigational antibody-drug conjugates. If BioNTech exercises an option, Autolus will be eligible to receive exercise fees and milestones payments, with low-single digit royalties on net sales of the licensed products.
|
CSIQ MSFT | Hot Stocks05:36 EST Recurrent secures Microsoft as customer for 127 MW solar project in Louisiana - Recurrent Energy, a subsidiary of Canadian Solar (CSIQ) and a global developer and owner of solar and energy storage assets, announced this week that it has secured $160M in project financing for its 127 MWdc Bayou Galion Solar project, located in Morehouse Parish in Northeast Louisiana. The project is currently under construction and is expected to be operational by fall 2024. Microsoft (MSFT) will purchase 100% of the energy and renewable energy credits produced by Bayou Galion Solar to support its goal to be carbon negative by 2030. The project will significantly expand the amount of renewable energy capacity installed in Louisiana. At the end of September 2023, Louisiana had 145 MW of operating wind, solar, and energy storage capacity. Mitsubishi UFJ Financial Group acted as Coordinating Lead Arranger for the financing.
|
MT | Hot Stocks05:35 EST ArcelorMittal sees FY24 capital expenditures $4.5B-$5B - The company said, "As anticipated, apparent demand conditions are now showing signs of improvement as the destocking phase reaches maturity. Despite continued headwinds to real demand, World ex-China apparent steel consumption ("ASC") in 2024 is expected to grow by +3.0% to +4.0% as compared to 2023."
|
DO BP | Hot Stocks05:13 EST Diamond Offshore executes two-year contract extension with BP subsidiary - Diamond Offshore (DO) announced that it has executed a two-year contract extension with a subsidiary of BP (BP) in the U.S. Gulf of Mexico for the Ocean BlackLion, commencing in September in direct continuation of the rig's current contract. This contract extension represents approximately $350M dollars of additional backlog. Additionally, the company has entered into a drilling contract with Serica Energy to utilize the Ocean Patriot for two plug and abandonment wells in the U.K. North Sea. The program is estimated to commence in March and to continue for approximately 60 days. The contract represents over $10M of additional backlog, excluding mobilization.
|
BABA | Hot Stocks05:10 EST Alibaba reports AliExpress order volume increased 60% - AliExpress order volume has increased by 60% year-over-year, according to the financial results announced by Alibaba for the quarter ended December 31, 2023. This performance contributed to a 44% year-over-year growth in Alibaba International Digital Commerce Group's revenue, exceeding market expectations for the sixth consecutive quarter.
|
JOBY | Hot Stocks05:06 EST Joby Aviation receives Part 145 Repair Station Certificate from FAA - Joby Aviation announced it has received its Part 145 Repair Station Certificate from the FAA, qualifying the Company to perform select maintenance activities on aircraft and marking another key step on the path to commercializing Joby's electric air taxi service.
|
GNTA | Hot Stocks05:05 EST Genenta Science doses first three TEM-GBM patients in Cohort 8 - Genenta Science announced that: "We have successfully dosed the first of three patients in Cohort 8 (Temferon(TM) at 4x10^6/kg), the last cohort of the Phase 1 dose-ranging part of the Phase 1/2 clinical trial in newly diagnosed uMGMT Glioblastoma Multiforme (TEM-GBM) patients. The second patient has been enrolled and the treatment is planned. Thus far, the preliminary data indicate no dose-limiting toxicities related to Temferon have been detected in any of 22 treated patients.Temferon-derived differentiated cells were evident within the peripheral blood 14 days after infusion and were still detectable at more than 24 months. As of December 2023, preliminary data in uMGMT patients, the most aggressive form of GBM, show a 2-year Overall Survival (OS) of 25%; the historically reported data observed in uMGMT and methilated patients undergoing current standard of care is approximately 14% to 18%, respectively. We expect reporting top line Phase 1 dose-ranging data by the end of 2Q24."
|